← The Joe Rogan Experience

Michael Osterholm

第1779期2022-02-18English

嘉宾:Michael Osterholm

#1779 - Michael Osterholm
收听本集00:00 / 2:32:43
阅读设置
按你的习惯阅读
正文字号
下载播客精读
把这一篇,带走慢慢读

精读待补充

下载功能还未开放

§01Transcript · 00:00–05:18

00:00The Joe Rogan experience

00:05Dr. Osterholm welcome back. Thank you very much very good to see you again.

00:16Good to see

00:16It's been basically two years from the day and I think when you were on the

00:21podcast

00:21For a lot of my friends that was the first real fear that they felt about the

00:27pandemic you scared the shit out of a lot of people

00:30Well, you know my job is not to scare anyone out of their wits

00:33It's to scare them into their wits ah and to do what they can to

00:36Deal with the situation as you know at that time March 10th of 2020 no one

00:42wanted to believe this was gonna be a pandemic

00:43And so yeah, there was a lot of denial about how it was gonna play out and

00:48people were thinking that it was

00:50Inflated or is not that big of a deal and then like I said when you came on the

00:55podcast that like I got a bunch of calls from

00:58friends like oh and Jesus

01:00Yeah, I think the

01:02Understanding of where we've been where we're at and where we're going still I

01:05think isn't really completely clear

01:07You where we're going in particular right now

01:09As an infectious disease expert, it's very rare that you have an opportunity

01:15during your lifetime during your career to examine

01:19a pandemic and to be through it and examine the responses to the pandemic, you

01:26know

01:27How when you look back at it what mistakes do you think were made and what do

01:33you think was done correctly?

01:35Well, first of all, let me just say that one of the things I think that's been

01:41missing

01:42From a lot of the response that we've had so far

01:44Is an incredible sense of humility humility every day

01:49When I get up the first thing I do is I look over at my nightstand and I see

01:53this crystal ball

01:54It has five inches of cake mud on it and I try to scrape it off and then decide

01:59what do I know for the rest of the day

02:00And I think that we've had far too many answers before we really had the

02:05answers

02:05And while we always want to use that term quote follow the science

02:10I think we didn't do a good job sharing with the public and even within

02:13ourselves

02:14What did we really know and not know and what did we have to do to learn more?

02:18So I'd say it's humility

02:20Do you think that it's overwhelming like the the reason is there a reason?

02:26Why they didn't do a good job sharing the information with the public?

02:29And do you think that some of that might be just the fact that

02:32being involved in something with that has such a

02:36massive footprint something that literally overwhelmed the entire planet earth

02:42That there's so many variables there's so many things to deal with there's so

02:46many things to manage that that became part of the problem

02:49Well, you know joe, I think that

02:52If I had to look at it there were days that I felt like I was trying to plant

02:57my petunias in a category 5 hurricane

02:59I mean, it was just one of those situations where there was so much going on

03:02look at the politicization

03:04Look at the misinformation disinformation

03:06I mean look at the debates they often weren't really about the substantive

03:10issues of what was happening

03:11And so we had a lot of these counter current issues and the question was what

03:16do we really know or not know about this virus?

03:19I mean, I'm sure there are people after I'm on here today

03:22They're not going to be happy at all with what I have to say because I don't

03:25think we're done yet

03:25And as I said a year ago right now a year ago right now

03:30When the world was basically seeing the curve come down from that early january

03:34peak

03:34And the vaccines were flowing that we were done. Everyone wanted to declare

03:38independence from covet

03:39And I said no, I think the darkest days of the pandemic could still be ahead of

03:44us because of variants these variants are really challenging

03:48We don't know what they're going to do. They kind of like 10 hundred 10 mile an

03:51hour curveballs

03:52And so I think that even going forward we surely are at a better place right

03:57now and we're going to be this for a while

04:00But I don't know what the next variant is going to bring and will it evade

04:03immune protection?

04:04Will it mean that the antibody the immune response we've had so far the vaccine

04:09protection we've had so far?

04:11What will it be like with the next variant?

04:13I don't know that maybe it's going to be fine

04:16Maybe we're going to see it become a regular old flu-like illness every year,

04:20but maybe not

04:21And I think that that's the challenge we have is that kind of humility to say

04:25we don't know

04:26And that's what's been a real problem trying to help the public understand it

04:30because we've had far too many answers when we really didn't

04:32There's an inclination to think that because omicron is so much more mild than

04:37delta

04:37That this is where the direction of the virus is going is that correct?

04:43That is the sense

04:45But there's a couple of assumptions there that I think really deserve comment

04:48number one

04:50The term it's a milder disease was really unfortunate in the sense that it gave

04:54everybody the sense that across the population

04:56It's a milder disease

04:59If you actually look at what happened, let's say you had a thousand cases of

05:02delta

05:02And a hundred of them would show up in the hospitals have severe illness and

05:07die someone would die

05:08Well, then along comes omicron instead of a hundred only ten people get serious

05:12illness or hospitalized you say

05:14This is a much milder disease the problem was you have 20 times as many cases

§02Transcript · 05:18–10:28

05:18occur

05:18So actually your health care systems are much more overwhelmed

05:21I mean, it wasn't just the total number of cases

05:24It was the severe cases and the last 12 weeks have been among the most severest

05:29weeks of the pandemic

05:31And it's just because the sheer number

05:33And so I think that that's one thing first of all

05:36This was a mild disease for a lot of people but for a whole lot more it wasn't

05:39I think number two is the fact that

05:42You know, we don't know what these variants are going to do they could be milder

05:45again

05:46But you know, we're in a very amazing place right now with a virus

05:50Where when you look at its original source from a human to another human

05:56Early on in wuhan, but you know, it had to come from an animal of at some point

06:01Well, now we're seeing all kinds of animal species infected with this virus

06:05Look at what's doing with white-tailed deer

06:07I mean in my 46 years in the business

06:09I've never seen data like I've watched the emergence of this new variant

06:13In in wild deer yeah, it's very strange, right?

06:16I mean, that's some in some places as many as 50 percent of the deer of

06:19antibodies

06:19Yeah, well, in fact, even if you look at studies like in iowa where they

06:23followed it and actually looked rogue kill deer

06:25So that was really random across the state

06:28They actually found looking for the actual virus

06:30Which was a delta-like virus that it actually paralleled the exact experience

06:34in humans

06:35So as the numbers in humans went way up the number and deer went way up where

06:38are they getting it?

06:39Yeah, that's the question, right?

06:40Are they getting it from the capid captive cervid industry?

06:43Well, I don't think it's there. I think it's

06:45Something because it's a statewide even where you don't have captive cervids

06:49They were seeing the same increase and decrease in cases

06:52So I think what it's really pointing out though is is that if you look at all

06:55the other animal species that get infected

06:57And then you look at the potential for humans to continue to get infected

07:01I don't know what the next variant is going to bring and no one can tell you

07:04that and if they do be careful

07:05Because they probably have a bridge to sell you. Yeah

07:07So you could have one it gets milder and we surely have four coronaviruses

07:12right now that typically cause milder disease cold-like symptoms

07:15Maybe it'll go that way on the other hand

07:18It may reassort meaning that it swaps out its genetic material like a flu virus

07:22does with other

07:23Coronaviruses and we could see a new punch it could actually evade immune

07:27protection

07:28We don't know that so I think the challenge we have is just being honest with

07:32everybody. This is the guardrail

07:33One side is it could go back to another omicron like experience or that may be

07:39the last one

07:40I hope for the last one being the mild one, but hope's not a strategy

07:45So you got to look at what do we need to do to be prepared and right now

07:48everybody in this country wants to back away back off and say

07:52We're done which I want to to I feel that but at the same time

07:56I have to say I don't know that we're done just like I said a year ago

07:59I thought the darkest days were still ahead of us now when you say that

08:03So omicron is far more contagious than delta and far far more contagious than

08:09the original variant. Yes, right now when you say that

08:13Maybe you know, whatever numbers are used that it's less likely to cause

08:17hospitalization

08:19But because it's infecting so many people you actually get more hospitalizations.

08:22That's exactly right

08:23So what are what's the cause like why are some people getting badly hit by it?

08:29Whereas other people it's just a runny nose

08:32Well, and we don't know

08:34We do know a couple of things about protection number one is

08:39If you've been vaccinated particularly if you've had the third dose if you've

08:43previously been infected

08:44Which also does add to your immunity clearly?

08:48Those obviously work in your favor if you have some of these underlying health

08:52issues that we've talked about which

08:54You know, it's not just about being in shape or not, you know people with

08:57diabetes people with asthma people are immunosuppressed

09:00There are 7.5 million

09:02Americans right now that are immunosuppressed either because of the disease

09:05they have they're being treated for cancer

09:08All those people are at much higher risk of having severe illness and even what

09:12we saw with kids

09:13We had never seen this level of activity as we see all with omicron with kids

09:18And so I think the challenge we have today is for hospitalizations. Yes, even

09:22for hospitalization

09:23Now the kids that were hospitalized did all of them have comorbidities?

09:27No, none of them did not so many some of them were not even obese. Yep, and

09:31they were hospitalized. Yes, absolutely really, yep

09:34omicron clearly really took a

09:36a hit on kids that's interesting because

09:40I in my kids school a few kids got omicron and it was uh essentially like

09:48Me or my friends who got it was very mild if you look at right now

09:52uh, just

09:55Through this up till this past month with most of this activity having been

09:58primarily in the last six weeks

10:001334 kids between the ages of zero and 17 have died from covet

10:061334 kids. Yep, and out of these kids how many had comorbidities? How many were

10:12obese?

10:12Some did but but a comorbidity is just obesity. Yes, in fact, let me come back

10:17and say

10:18Somebody who has diabetes is considered having a comorbidity if you look at

10:23somebody who has

10:24uh, asthma which you know about seven percent of all the asthma in the country

§03Transcript · 10:28–15:53

10:28is in kids all sorts of autoimmune diseases

10:30Exactly, so all of those add to it. Right, and and so that's been part of the

10:34real challenge we've had with this

10:36But for normal healthy kids is this something that's more dangerous than delta?

10:41Absolutely, it was it's really absolutely

10:43It was that is that is that shocking to you because it seems like for adults

10:48The the effect that it has on the general population

10:51It seems that the the consensus is that it's more mild

10:55Yeah, I think that's one of the challenges we have if you've known

10:59The covet 19 pandemic

11:02In 2020 and you knew it in 2021 doesn't mean how well you know it today

11:08Because things have changed right for example

11:10If you look at the infectiousness in kids the early data we had on how well

11:15this virus transmits in kids was before we ever had the alpha variant

11:18Which showed up in roughly december of 2020 into to january 2021?

11:25And we found limited transmission in kids limited severe illness

11:29Then alpha came along and we saw much more transmission

11:32We had places in this country that had large outbreaks school-based outbreaks

11:36Then that kind of went away then delta came and added even more transmission

11:40with kids than we'd seen before and omicron was the king

11:43And so I think if you knew

11:45COVID-19 back in 2020 you didn't necessarily know it today in terms of the

11:50infectiousness

11:51And what we saw happen, so I think that's one of the challenges

11:55We have is just keeping up to date and what it did and how it did it with kids

11:59And the variants uh as they like so the there's the original version and the

12:05alpha version is the first variant that was discovered

12:07Well, yeah, that's they what they've labeled them by is the greek alphabet

12:11So alpha was kind of the first one there and then we've had

12:14Not not a not the original virus, but the first variant of the virus. Yeah

12:18Well, what's really interesting with this virus is the fact that if you look at

12:22we call the ancestral variant the one that originated in wuhan

12:26All the subsequent variants we've seen have actually all gone back in their

12:30roots or in that ancestral variant

12:33It doesn't mean that if you had elf it turns into delta with a little bit more

12:37changes

12:37It turns into omicron every one of them have a distinct line back to the

12:41original variant

12:42And that's one of the challenges we have because that's going to continue to

12:46happen where we're going to continue to see these new variants show up

12:49And as far as

12:53The variants that are in play right now like what percentage of the the

12:58infections right now or omicron what percentage or delta?

13:01Is there any of the original variant left?

13:04The original variant surely is out there because we keep seeing these new

13:07variants come from it

13:09So it has to be somewhere. I can't tell you where it's at the variants don't

13:12come from like delta creating a new variant

13:15So it's it's actually takes take you back to the original variant

13:18So the question on omicron's industry when right now in the united states

13:21virtually 100 percent of the variants we see are omicron

13:25They've taken a hundred percent

13:27100 percent in the u.s and virtually around the world it's beaten out delta

13:30completely

13:31If you look in the united states there are three sub-lineages of that variant

13:35what we call ba1 ba2 and ba3

13:38And we're watching a battle go on right now between the those sub-variants and

13:43it turned out ba1 was the original one

13:45We first saw kind of the original omicron

13:47But ba2 which appears to be more infectious now is beating out omicron in some

13:52countries in the world

13:53It's become the dominant variant in the united states is still a a small

13:57percentage, but it's growing last week

14:00It was four percent the previous week was one percent. So we don't know what

14:04that's going to mean in terms of seeing more

14:06of the

14:08ba2 variant emerge

14:11How do they make the distinction between omicron delta omicron and then ba1 ba2?

14:16Why do they decide that this isn't another variant? Why do they just keep

14:20calling it omicron?

14:21Yeah

14:23And and and this is one of those questions where I clearly i'm not the world's

14:26expert on the

14:28Overall genetics of this virus, but i'll tell you that

14:30The mutations that occur surely can accumulate if you look right now for

14:36example, there's more difference

14:37Genetically between ba1 and ba2 than there is between the ancestral virus and

14:42alpha really?

14:43Yes, so it has to do pretty much how it evolved out of that ancestral virus

14:48tree and is it different enough and so

14:51You know there's been discussion that there may actually be some effort made to

14:55consider ba2

14:56As a new variant of concern by itself

14:58So but but this is I think the message here is this is what we have to continue

15:03to be mindful of

15:04I know everybody wants me to say today we're done and I hope we're done

15:08But as I said just a moment ago hope's not a strategy

15:11Right

15:11I think that we could still see the emergence of new variants that could

15:15challenge the immunity that we have already

15:18Which is what makes this virus so difficult and so different than we've had

15:22before when you see influenza

15:24Pandemic influenza occurs because a bird virus finally evolves out of the bird

15:29gets into particularly a pig because a pig has a lung

15:32So it has receptor cells for both human viruses and bird viruses

15:37And when they get into a pig cell in particular they combine they mix up

15:40The flu viruses are very promiscuous and they come up with this brand new

15:44strain that causes the next pandemic

15:46Well when that spillover occurs into humans, that's kind of the

15:49Seminal event the rest of it emerges pretty much in humans

§04Transcript · 15:53–21:03

15:53We don't necessarily see us giving it back to the animals they give it back to

15:57us we give it to the animals

15:58They give it back to us with

16:00Looking at SARS-CoV-2 in the and this particular coronavirus

16:03We don't know what it's going to do is it going to go back and forth between

16:07animals

16:08I mean, I could line list an entire

16:10Set of all the animals that are now infected with this virus

16:13And we don't know what that means the first ones that we found that trans

16:17Transmit from humans to animals or back to in in terms of SARS-CoV-2

16:23Was it ferrets like what was the first animal that they discovered that uh

16:27humans can infect and they can infect us with us?

16:29Well, there was

16:31Game animals mink and so forth in europe that we saw that

16:35But it became clear because we started seeing zoo animals infected right just

16:39this past week

16:40We've heard about lowland gorillas and stuff cats we've seen dogs and cats in

16:43people's homes where there were cases

16:45And they got the white-tailed deer. I think there's a whole number of animal

16:49species where ultimately they could be infected with this virus

16:52And the trillion dollar question

16:54We don't know will that in any way shape or form contribute to a

16:58Spillback moment into humans with the new virus that again will challenge

17:02Our immune systems challenge our protection and what does that mean?

17:06And we just don't know is that the term they use by a lot or animal reservoir.

17:10Yes, absolutely. That's it

17:11So that's um any other animal that can catch it now is that

17:15We'll catch it and keep it going

17:17Inside them. So sometimes an animal may get an infection from us and it's

17:21terminal it ends

17:22It doesn't keep going in the animal population

17:24But as we just talked about the white-tailed deer

17:25Clearly there the virus is ongoing with transmission in the deer population

17:31itself

17:31Are there any examples of an animal being infected and then like from a human

17:36like a human giving it to their cat for instance?

17:39And then the cat giving it to another human

17:41You know, it's

17:43Unclear and when I say unclear there was surely some data

17:46Looking at the game farms where it was thought that some of the transmission

17:50was from human to animal animal back to human

17:52When you say game farms, are you talking about like captive coven?

17:55Captive survey rather in this game what we're talking about are primarily fur-bearing

18:00animals for pelts, you know, the mink

18:02Ferrets that type of animals. So that's where they first started to see the

18:06transmission?

18:07Well, it's suspected. It's never been confirmed, but it's been suspected there

18:11There's been some discussion and follow-up on people's homes where somebody got

18:17infected

18:17The animal was infected the dog or the cat and somebody else got infected in

18:21the home

18:22Well, it could just easily been person to person the animal is incidental

18:25So I don't think we have any good examples of a human to an animal and an

18:29animal back to a human

18:31There was a recent outbreak in hong kong

18:33It's now emerged into a large outbreak where they thought that hamsters were

18:37potentially being sold in pet stores were involved with

18:39Being infected and transmitting, but I think the data still are out on did the

18:44hamsters really transmit back to people

18:46They were definitely infected, but I don't know if they transmitted back to

18:49people

18:50Now this virus are there parallels to other viruses that we could look to and

18:55and see this kind of similar pattern emerging

18:59particularly with like

19:01transmitting it into these other animals and then the potential of those these

19:04animals transmitting into the people

19:06It seems like there's so many different species that have it. Yeah

19:10You know, we really don't have one like this particularly that can cause such

19:15A widespread disease. I mean when you think about omicron for example, you know

19:19when this first emerged in november

19:21I coined the term a viral blizzard because to me that's what it looked like was

19:24going to be

19:25It was just going to flood the world if you look at alpha and delta and all

19:29these other took weeks in some cases months

19:32Before it spread around the world

19:34This one spread around the world literally overnight and you know

19:38We're now seeing major activity in the western pacific region, you know in in hong

19:42kong

19:43Likely in china's we're not hearing enough about it korea, etc

19:47But most of the rest of the world's already been hit hard and over it. Well,

19:51that is like a blizzard what it did

19:52We've not seen that with any other animal related virus in humans even

19:58influenza hasn't done what omicron's done

20:00In that way

20:02Now in the beginning of the pandemic you were of the opinion that this was

20:08from a natural spillover

20:11from the the origin of

20:13SARS-CoV-2 was most likely from an animal that it spilled over into human

20:20beings. Do you still have that opinion?

20:24Well, again, let me clarify what I said and and have maintained all along

20:29because I too have concerns about

20:31The potential for what we call gain of function or or clearly biosecurity of

20:37laboratories leaking out of of labs

20:39I hadn't have not seen any evidence at all that would support that number one

20:44This was a man-made virus absolutely none zero no evidence that would support

20:47that it is a man-made virus

20:48None whatsoever and I again with my limited expertise in viral genetics

20:53I believe the people who I work with now the question is could it however been

20:58in that lab

20:59And spilled out because somebody got infected there was a lab accident which

§05Transcript · 21:03–26:00

21:03surely can happen

21:04and again, we don't have

21:06Any conclusive evidence that that happened. I think even anecdotal evidence we've

21:11had has been very short, but i'm the first one to say

21:14I wish we'd had a much more exhaustive

21:17Investigation into what happened at that laboratory which much more

21:21transparency

21:22I don't think we've had that kind of a transparent investigation yet

21:25To see were there sick people at that time because if it was going to spread

21:29out into the population there would be sick people

21:31On the other hand

21:33I'm not surprised that it might have emerged in wuhan because here's a you know

21:37An area of over 40 million people living in that whole area for which their

21:41food sources come from hundreds to up to a thousand miles away

21:44Of which the open markets there are ripe with the kind of animals that very

21:48well could have brought the virus there

21:50And when you look now at the ease at which this virus goes between animals and

21:55humans at least

21:56Initially or humans or back to animals

21:59It's not surprising that it might have emerged there

22:02And so I am still open to the fact that was it a laboratory accident

22:07I don't have any reason to believe it was an intentional one

22:10I know it was based on everything we have it was man-made

22:13But I don't think anybody thinks it's an intentional release do they?

22:16No, well some people have no some people think

22:18Well of course I shouldn't say anybody

22:20Yeah, yeah

22:20Some people believe the world's flat

22:21Right, that's absolutely true too

22:23That's absolutely true too

22:24So I think no that but I think that it is fair to say

22:28That there still remains this question could have leaked out of that lab and I

22:32continue to say

22:33I wish we would have

22:36An exhaustive comprehensive investigation which the chinese government would

22:41agree to

22:41Is that part of the problem a lack of transparency?

22:44I think it is but let me let me paint a picture here that also helps explain

22:48the situation

22:49Imagine a brand new virus emerged in the caribbean

22:52Okay, I mean it came from nowhere. It might be a mosquito born something. Okay

22:58Where do you think they might find that virus first?

23:00Atlanta

23:02Why Atlanta? Because it's the industry it's a transportation hub for the caribbean

23:05And they have the sophisticated laboratories there not even at the cdc. I'm

23:10just talking about universities, etc clinicals

23:12Imagine if that virus was found in atlanta a brand new virus the assumption we

23:18made immediately it came from the cdc

23:20Because it's there geographically there. It's in atlanta. That has to be the

23:25source. I see what you're saying

23:26And so if that were the case

23:28Imagine the russians and the chinese saying wait a minute. This was a lab leak

23:32out of cdc. We want to come and investigate

23:34We're going to come in and see

23:37Do you think the us would just willy-nilly open up the lab at the cdc to the russians

23:41and the chinese right so in some ways?

23:43I i'm not being sympathetic at all the chinese because I think they are

23:47continuing to make the problem worse by not providing more transparency

23:51But at the same time if the same thing happened in the united states

23:54I could see where we wouldn't just open up the cdc to everybody in the world to

23:57say okay come on in and look

23:59Right, but is the cdc doing gain-of-function research on coronaviruses?

24:03They're not they're not well, so if something emerged from there

24:06That wasn't something they were working on that would probably not arouse the

24:11suspicion of the world

24:12I think part of the problem with what's going on in wuhan was

24:16That lab is a level four lab that was working on

24:20Bat-borne

24:22Absolutely right about that, but at the same time cdc might be working on a lot

24:26of the viruses that would emerge in the caribbean

24:28And they would have labs that were working in that because some of their best

24:32expertise is on for example mosquito board viruses in there

24:35So i'm merely pointing out that

24:37It's not just the fact that the chinese have basically stonewall this they have

24:43And unfortunately, I think that that can be interpreted as you know, there's

24:48definitely guilt there, right?

24:49I think some of it has to do with this issue where they just opened their lab

24:52up

24:52I just wish they would and let us let that an independent group from around the

24:57world go in

24:57Examine all the records was there any evidence of illness around that time was

25:03there any unusual activity?

25:05You know the viruses they have what they've self-reported were not any that

25:10were

25:10Close to this one in terms of actually yeah that actual virus was in the lab

25:16that was suddenly found in wuhan

25:17So I think it's a continues to be a major distraction

25:20Wasn't there recently a version of the virus that was discovered a very early

25:26version of covid 19 in one of the labs?

25:29There's been a number of of

25:31SARS-CoV-2 like viruses there, but again, this is out of my area of expertise,

25:37but the

25:37Viral genesis I know would say

25:39There surely is not the direct link yet that that virus came from that virus in

25:44the lab

25:45And so I think that but but that's the kind of thing we need to have the

25:48transparency on and and I wish we'd move on

25:50I wish we'd move on then so the part of the issue is that there's just not

25:55enough data from them to make an accurate

25:59honest

§06Transcript · 26:00–31:11

26:00Clear determination that's what I see and I do see a virus that right now

26:06Sure is very effective at moving between people to animals right so it doesn't

26:10surprise me that it could move from animals to humans

26:13Now the people that are suspicious that this did come from some game of gain-of-function

26:17research

26:18They point to that as an indicator that this is a virus that was at least

26:24cultivated in a laboratory, right?

26:26Yeah, and I see no evidence of that and let me just come back and add a context

26:30to this

26:31I sat for a number of years on what was the newly established

26:35Basic group inside of the federal government to look at biosafety and biosecurity

26:40work

26:41Okay, the national science

26:43Group that did that and you know for all the years from 2005 to 2012 that I was

26:49on that

26:49I was one of the really outspoken people about my concern about doing influenza

26:55work

26:55In labs where they were trying to understand

26:58Virus h5n1 a bird virus that occasionally infects humans

27:03But could it one day become the next pandemic virus and a group of researchers

27:07wanted to try to gen up that virus

27:09By passing it multiple times in ferrets and looking to see can we predict when

27:14it might become readily transmissible between mammals?

27:16I.e could it affect humans and my concern was all along wait a minute. What

27:20happens if this gets out?

27:21What's the challenge you could start the next flu pandemic?

27:25So I have always considered myself kind of the champion in a way as amongst

27:29others of looking at biosecurity as a really critical issue

27:32So I I come into this with the wuhan experience feeling the same way. I think

27:37this is an important issue

27:38I think it needs further discussion

27:40But again, I don't see any evidence at this point that anyone has provided that

27:45shares that this is what happened

27:47But I think we just need that transparency. We don't have yet

27:50So there's not enough evidence to draw a clear conclusion in your opinion

27:54None and I there is some anecdotal evidence, right? There was uh, some I

27:58believe there was three

27:59Researchers at the wuhan lab who did get ill

28:03Uh with a very similar disease to covet 19 and one of their spouses wound up

28:09dying

28:10And there was some indication that that could have been the initial source

28:14Yeah, you know

28:16Let me first of all just say in my world anecdotal evidence is not really

28:19evidence, you know

28:20It's it's it's it's it's that storytelling, but you know, I see some of these

28:24things

28:25Yeah, and you know, I've never seen any of those data corroborated by any

28:29Responsible group. It's kind of one off, you know, it's kind of that old idea

28:33You know, president kennedy's secretary was named lincoln president lincoln

28:37secretary is named kennedy

28:38So there must be a tie between the two assassinations, you know, it's that kind

28:41of thing. Yeah

28:42I've seen nothing that supports that activity

28:45Okay, so as a scientist, you're just not willing to make that leap

28:48I'm not willing to make the leap, but i'm unwilling to make the leap if we get

28:51the evidence that it's there

28:52So i'm not sitting here saying write it off right. I get it. I get it. Yeah

28:56Um in the the early days there there was some evidence that

29:00Was deleted there was a lot of files that were deleted from the wuhan lab

29:05And that a lot of people pointed to that as being an indicator that they were

29:09not not just not being transparent

29:11But withholding some data

29:14Yeah, I at this point I can't comment on that to say I know exactly what

29:19happened

29:19There surely was some evidence that there had been some files moved or deleted

29:24Also, there's been evidence that some of those files have been replaced, etc

29:28So I I can't comment beyond that

29:30But again, the people that I most respect in this business who have concerns

29:35like I have have not pointed to that as being any evidence

29:38Necessarily that that's what happened was that there was data that they wanted

29:43to get rid of so people wouldn't see it

29:45Right, it's just again not enough, right? Is that what you're saying?

29:49Yeah, in fact, I wouldn't even say not enough

29:52I would say I'm still waiting for

29:54Even a limited smoking gun to come forward and say that I just haven't seen

29:58anything like that

29:59I'm open to it. I'm willing to it. I've said time and time again

30:03I wish that their Chinese would allow for an exhaustive

30:06outside review of what happened there to corroborate all these pieces of

30:11information or basically

30:13Show that they're not true

30:16And I think that would put us all in a better place of trying to move forward.

30:20Is there proof that they deleted evidence?

30:22I don't have any proof of that. I don't know. You don't know. I don't know

30:27If there was proof that a lot of files were deleted would you would that give

30:31you pause?

30:32Well, I'd want to know why you know

30:33We delete files all the time on research things after things are completed now

30:38on the other hand laboratories

30:39typically are

30:41Keep everything forever because they may have to go back to it at a later date

30:45So, you know, I can't comment on that other than to say that should be pieces

30:49of evidence or pieces of investigation

30:52That would address that now

30:54One of the things I think that you said early on in the pandemic was you didn't

30:58think that it would

30:59That it had emerged from a lab

31:01You thought it was a natural spillover just simply because of the design of the

31:05virus itself that we wouldn't design something like that

31:07Yeah, and I still say that that's the case

§07Transcript · 31:11–36:12

31:11I mean this thing is so effective at

31:14Infecting humans and it only got better over time think what it did in mother

31:18nature since the first omicron or since the first variant occurred

31:22Up to omicron and you can see it just got better and better at infecting humans

31:26without any hand of a man-made event

31:29And so this thing was an evolving virus right from the start that was

31:33Basically capable of infecting humans and got better at infecting humans as

31:37time went on

31:38So the accusations or the people that think that it was made in a lab how do

31:43they think that?

31:44Something like that would be created and why do you think that that's not the

31:49case?

31:49Well, again, this is out of my sphere of expertise

31:52I am not the person who can tell you from a genetic standpoint how to

31:55manipulate this virus and what to do it as an epidemiologist

31:58I can tell you, you know, I've seen these other spillover events

32:01I've been very involved with investigating SARS

32:04Back in 2003 when it first emerged in China spread around the world

32:08I've been very involved with the work with MERS the Middle Eastern respiratory

32:12syndrome another coronavirus

32:13And in each one of those you can show clearly the spillover event from animals

32:19to humans

32:20In fact with the camels being the Bain Reservoir for MERS in the Arabian

32:24Peninsula

32:25We keep having MERS cases because nobody's going to put down all these camels,

32:29you know, we're not going to get rid of them

32:30And so we watch those spillovers occur from time to time into humans

32:34So coronavirus is emerging out of an animal reservoir

32:38In and of themselves are not unusual

32:40It's not somehow like A plus B plus C plus miracle ended up with the answer

32:45So I I haven't seen anything that would tell me that that was any different

32:49than that

32:50But again, I'm wide open to whatever new data can come forward and I hope we do

32:55exhaustively look at this

32:56Now when they perform gain-of-function research, can you can you explain how

33:01that's done?

33:02They're they're using

33:04Different coronaviruses and and various viruses and infecting human respiratory

33:11tissue

33:11And they're also doing experiments on ferrets because they have very similar

33:16ace-2 receptors to human beings

33:18Right is that the case?

33:20I can't comment on what research they're doing. I don't know. You don't know. I

33:24don't know that

33:24But you do know how gain-of-function is done, right?

33:29Well gain-of-function first of all means that you're adding something to the

33:33virus like I talked about with influenza

33:35It was a gain-of-function

33:36We were trying to see if you could make it transmissible between in this case

33:40an animal species and a human

33:42Or you're trying to make it so that it is actually more infectious or you're

33:46trying to make it so that it kills it

33:48It does more damage

33:49And those are all considered parts of gain-of-function in other words trying to

33:54make it do something else

33:55So in terms of the

33:56coronaviruses, I've not seen any evidence of again gain-of-function because

34:02This virus is pretty damn functional on its own it's doing very well and it's

34:06teaching us by just watching it

34:08how it's changing to become

34:11Almost a sense of a gain-of-function of mother nature

34:14Right, but the way that these experiments are done are when they're infecting

34:19human respiratory tissue when they're infecting ferrets

34:23And they're doing it purposefully for these experiments

34:25Aren't they allowing selection and evolution to do the work for them?

34:30I mean I don't necessarily think they're manipulating the virus aren't they

34:33allowing the virus to go through

34:36Its normal processes, but they're doing it purposely, right? Is that the case?

34:41In the principle what you laid out that's the case, what I'm saying is I don't

34:45know that they're doing that

34:47I have not seen any evidence. It could exist. I just don't know. I'm not trying

34:52not to answer

34:52Doing any of those studies where they're trying to make it more transmissible

34:56or that they did do that. I just don't know

34:59I thought that was the entire argument that that even the NIH had laid out that

35:04they had done

35:05Well, that had come up and as you know

35:08Equal Alliance the group that was doing the work

35:11EcoHealth Alliance

35:12Yeah, EcoHealth Alliance

35:13Actually, yeah, I disagreed with that so that's not what's being done

35:17They said they disagreed with it. Yeah, and I saw I can't comment. I don't know

35:21Right because this was like the arguments between Rand Paul and Dr.

35:24Fauci and you know was get very contentious about the definition of gain of

35:28function. Right, right

35:29Do you think it's just splitting hairs or do you think this is?

35:32Well, I think anytime you consider gain of function for any virus

35:36It's an important issue because of the potential for it to do more harm

35:40particularly if it's accidentally released which can happen

35:43Again, I don't have any first-hand or second-hand knowledge that that was what

35:47was being done in Wuhan

35:48But if they were doing gain of function, that's how they would do it

35:52They would infect human respiratory tissue and they would infect various

35:56animals

35:56And they would study how this virus progresses and how it evolves and selects.

36:01Is that the case?

36:02Well, that's one way to do gain of function, but because i'm not a coronavirus

36:06Virologist, I can't tell you if that's what they're doing with this or not or

36:09if they have done that. I just don't know

36:11Right

§08Transcript · 36:12–41:12

36:12And do you know if someone or a laboratory had done something like that and

36:17they had gone through these steps to

36:19use

36:21Evolution in terms of like infecting this human respiratory tissue infecting

36:25ferrets who have the similar ace2 receptors

36:27That this would somehow or another make a virus more

36:31Transmissible to people. Yeah, that's the idea behind it. You know, yeah, and

36:37again, I just come back to the fact that

36:39You know, you don't need to set up a research study today to do gain of

36:43function with this virus watch it in people

36:46Watch what it's doing on its own right?

36:47But that's once it's been released correct once it's been released

36:51If we're looking at the origins of it, I mean, this is what's concerning to

36:54people, right?

36:55They're wondering like was this

36:57avoidable

37:00During the obama administration didn't obama put the kibosh on gain of function

37:04research

37:06It was limited in the sense that it was for all gain of function or research or

37:09how you actually were going to go about doing it

37:12And showing the safety steps you had in place to make sure that it couldn't be

37:16a release a good example

37:18Is we do want to know if flu viruses leave a mark that says we're about to

37:23become a human to human transmitted virus

37:25So we can plan for that. So we do want to do some of this, but we want to do it

37:29safely

37:30And what i'm suggesting here is I don't know and yeah, what happened in this

37:35lab or how it did it

37:36I'd love to see that transparent information come out. I just can't comment. Is

37:40it safe to say that?

37:42That this kind of research is important to understand how these viruses evolve

37:49how they become more virulent

37:51How they can infect people and jump species that it it has to be done safely,

37:56but it's

37:58There's benefit there surely can be benefit and there's risk and this is all

38:01about the risk benefit equation

38:03And I think that's what the whole purpose of what the nih evaluation was of

38:07when can we

38:08Declare that there's a benefit here

38:11And this is the risk and we can actually address the risk and therefore the

38:15benefit is worth doing

38:17And you know you can't unring a bell

38:19So i'm one of those people that am very concerned. I don't want to find out

38:23later. I wish we had taken more caution

38:25Right, okay, my problem is I for this discussion

38:28I just can't comment on what happened at wuhan because I don't right of course

38:31Well, you're a scientist and you look at the evidence you look at it

38:34How's and there's just not enough of it, right? Is that safe to say?

38:38Yeah, and and i'm open to any new information as I said before that comes

38:42forward

38:42Did you read any of those emails where there was discussions that was were

38:48about

38:48The narrative of whether or not it had come from a lab leak and deterring that

38:52narrative

38:53I didn't read any of that. I didn't I you know, I didn't really you know if

38:57something substantive come out, but I you know

38:59Uh, you know, I already spend way too many hours a day working on code

39:04The last thing I have time for is basically getting into these politics, you

39:09know

39:10You know, and as you know, I mean, it's

39:13Oftentimes the kind of almost entertainment debate about wait

39:18He did this he did that who did this what did that and trying to trace it all

39:22back and so for me

39:23You know, if there's substantive information, I want to read it

39:27I want to know about it if I can't understand it

39:29I want to ask people who do know because there's a lot of the parts of this as

39:32I said

39:33With humility, I don't understand as an epidemiologist

39:36I think I have a pretty good handle on what the virus is doing in terms of how

39:39it acts in people

39:40But this particular area really does require

39:44A really level of scientific excellence in this area for which we have people

39:49who have continued to pursue this and so

39:51We'll go for it and I would like to see what they come up with

39:54So as an epidemiologist you are just trying to follow the facts of the disease

39:59and avoid the weeds

40:00Exactly okay

40:01And and and and be really clear about this is that I think that

40:06We have to have these discussions with how we have them they have to be based

40:10on data

40:11What we can't do is more, you know, it's like the kennedy lincoln analogy

40:14I just used and now it proves the point

40:16So therefore now the assumption as well, they are linked let's I can tell you

40:20the cia of you know

40:21Of the 1860s were still active back then and they're still active in the kennedy

40:27era, you know

40:28That does not help and to me that's where a lot of people find they spend time

40:32I don't

40:32I don't know if that's a good analogy like see what you're saying

40:36But we actually have the the actual people that were trying to say that it

40:42seems like this is coming from a lab

40:43And then and these were credible people from

40:46Legitimate universities and then you had some other people that were trying to

40:50say we need to disparage these people

40:52And we need to look at them as if they're fringe conspiracy theorists

40:56Yeah, I think in the early days that happened in a way that that happened

41:00Um, you know, I can't comment. I wasn't part of that discussion

41:04I did not get involved with that discussion because I felt like it was

41:07You know, it was in the weeds in a way that you know

41:10I was trying to figure out what this virus is going to do to kill people and

§09Transcript · 41:12–46:29

41:12how I could stop it from happening

41:14So to me again, I will let the experts who have that kind of expertise deal

41:19with it

41:19And rather than he said she said I just I stay out of it got it. That's why

41:25when I tell you what I know

41:26You better count on it's true

41:28I but I tell you that I don't know something then you can take that to the bank

41:31too and say he just didn't know

41:32I appreciate that

41:34Um, what about what one of the weird things is of this virus in the early days

41:39was how many people were asymptomatic?

41:41And you know, and it didn't matter by age

41:45It seemed like there was quite a few older people that were asymptomatic that

41:48got it

41:49And do you think what do you think the reason for that is?

41:53I don't know

41:54And I can tell you right now that is a point of discussion i've had oftentimes

41:58with my colleagues

41:59We do know that it's not likely tied to dose

42:02Originally, you know, I was a co-author

42:04You mean by viral load?

42:05Yeah, by viral load how much virus is there didn't dictate how seriously ill

42:10you did

42:10It doesn't mean you didn't get infected or not and we're still looking at that

42:14what it does indicate is

42:15Clearly having these comorbidities adds to the likelihood that once you get

42:21infected you're going to have severe illness

42:23Right, but as you just pointed out and is absolutely true. We've seen people

42:26who have comorbidities who've had mild disease

42:28We've had people for unexplained reasons. We don't know why have had serious

42:33disease

42:34Younger healthy no underlying comorbidities, you know physically fit and so

42:39Generally speaking though you can say that no in fact if you have these comorbidities

42:45you are much more likely to have severe illness

42:46But it's not totally the rule. There are those exceptions we see and as I just

42:51mentioned these kids

42:52You know a number of these kids did have comorbidities

42:55But some didn't and why they got infected and died. I don't know

43:00Is it a is there a parallel to any other disease that you've ever studied

43:05before or that scientists have studied like is there any disease that behaves

43:09this way?

43:09Well, clearly there are a number of viruses where

43:13The seriousness of the illness can vary a great deal by age for example

43:17Let me just take one that is not a respiratory transmitted agent, but

43:21The virus that causes hepatitis a or infectious hepatitis

43:24In young kids. This is often a very mild totally asymptomatic infection

43:30And it's transmitted from fecal oral, you know if you have diaper changing etc.

43:34It's not hygiene is not there

43:36We would often pick up outbreaks of hepatitis a

43:39Because parents would come down with it and they'd get really sick their livers

43:44would be in trouble

43:45You know, they get very yellow and jaundiced and we go back and test the child

43:49and sure not the child had been infected already

43:51And brought it home to mom and dad

43:53And so in a disease like that the percentage of people who have serious illness

43:58who get infected and have illness in general

44:01Is much higher than the older population that is the younger population where

44:04it's almost a mild disease

44:06So we have examples like that that do happen. It's not as if it's an unusual

44:11situation

44:11And for some diseases the vast majority of illnesses are mild asymptomatic

44:16You only pick them up by doing blood studies and populations for other diseases

44:20Well rabies is of course the classic example. It's virtually 100% fatal

44:24And so it it varies across all the viruses we have

44:28So is the high the percentage

44:31Unusual of people that are asymptomatic with this disease

44:36Well, you know, I think joe that's one of those questions again that kind of

44:40begs the very issue of what is this

44:43SARS-CoV-2 virus all about because if you go from the beginning of the covet

44:47pandemic to now

44:48Look at how different the ancestral variant illness was to alpha

44:52The delta to omicron it's just in a matter of two years, right?

44:57I mean, it's amazing how change how much and and the question you asked me

45:00earlier about the issue with omicron

45:03You know, why do we see so many infections out there because it's much more

45:06infectious

45:07And I think that what we're watching here is a really real-time evolution of a

45:13virus

45:13That you know, we could never you know

45:16Suggest for a moment that the measles virus is going to change a whole lot in

45:20two years

45:20It hasn't changed basically in decades and decades and decades

45:24So I think this is one of the challenges we have is that and when I answered

45:27your question earlier about what is the future of this pandemic?

45:30It's because this virus keeps throwing 10 210 mile-an-hour curveballs at us

45:34And I don't know what the future is going to bring yet

45:36Maybe one of these variants is going to spin out of this that is going to again

45:40cause various

45:41A large number of cases some of it's severe and is going to evade the immune

45:47protection that we have already

45:49I've read some articles that seem to indicate that there

45:54There may be some immunity that certain people have

45:58Because of previous infection for other coronaviruses other coronaviruses

46:03meaning common coronaviruses

46:04That somehow or another that may have imparted some

46:09At least some kind of either immunity or some kind of protection

46:14from SARS-CoV-2

46:16And that is currently being studied and in fact if you look at

46:20The issue of just take immunity from SARS-CoV-2

46:25If you look at the data for delta

§10Transcript · 46:29–51:44

46:29You could actually show that

46:31Basically, those people who had previous infection

46:35Did better than those who hadn't had previous infection and were vaccinated

46:41I mean actually they had more protection

46:43But if you go back to alpha

46:45People who had previously been infected

46:48Were more likely to get reinfected than people who were vaccinated

46:52So people who caught the alpha variant could catch it again?

46:56Yes, well everybody look at delta delta the same way people

47:00We have delta more than once

47:02Oh, it's not. I'm sorry. I'm talking about when they actually have the next

47:06variant

47:07So people have who had had alpha did get delta people who had delta got omicron

47:12And it's really too early for us to say

47:14What happens with ba1 ba2 can you get omicron a second time? We don't know yet

47:19But so when I was talking about for the alpha issue

47:22We were talking about people who had previously been infected with the

47:26ancestral variant now actually with alpha

47:29We're basically more likely to be protected by vaccine than previous infection

47:35For delta if you had delta basically

47:38You were less likely to be protected from vaccine and more so from previous

47:44infection

47:44And so what it's pointing out is this is a fluid situation and and

47:49We're still trying to learn with omicron. We had a lot of breakthrough

47:53infections with omicron, you know

47:54What was it that protected you or didn't protect you?

47:57With omicron and and we're still really looking at that issue

48:01And that is with people that have been previously infected as well as people

48:05who have been vaccinated with omicron, correct?

48:07Right, right

48:08So if you if you look at just hospitalization alone

48:10If you were unvaccinated you had about a 79.6 per hundred thousand people were

48:17hospitalized

48:17If you were fully vaccinated only 4.4 percent, okay?

48:21So 79 people out of a hundred thousand were hospitalized if you're unvaccinated

48:26And it was 4.4 if you were in fact previously vaccinated

48:31Four people 4.4 people versus 79 people?

48:34Yep, yep, right

48:35So a lot of people thought it was a lot higher than that

48:38Like there was an impression that when you got infected by SARS-CoV-2

48:43there was whichever variant that you had a high likelihood of being

48:47hospitalized

48:48Yeah, and this is for omicron remember we just talked about the fact that for

48:52many people who are infected

48:53You know, you didn't even get seriously ill

48:55Right

48:56But for those that did, yeah, they were seriously ill the number of deaths were

49:00elevated

49:01Do you think that there was a wasted opportunity to discuss metabolic health?

49:06Metabolic health in terms of weight loss in terms of taking care of yourself

49:12and eating correctly and vitamin supplementation and

49:16Exercise all these things were kind of ignored during the pandemic

49:20Well, you know, I

49:22I don't know if I agree with that because I mean, I surely have heard it over

49:26and over again that this was important

49:28But it's important for everyday life. I mean, basically whether you have

49:33Omicron or delta or SARS-CoV-2 at all, these are important things that you

49:38should be considering

49:39Okay, I think that that was reinforced by the government

49:41Oh, I think particularly around body mass index a lot. Really? Oh, yes, I think

49:45so. I mean, I

49:47gave many talks where I was talking about

49:50You might have given many talks

49:51But I mean, this is not something that was like echoed by the white house where

49:53they were talking about it openly in public

49:55Hey folks, you got to lose weight

49:56Well, I think that if you

49:59Look at

50:00Just even the recent weeks in terms of the discussions about comorbidities and

50:05what they are

50:06You have to separate out those ones which you can control

50:08Such as as you said, you know the exercise that type of thing those which are

50:14unfortunately just a part of your health profile

50:17diabetes

50:18Asthma

50:19Autoimmune disorders

50:20Autoimmune diseases, etc. So, you know, I fully support the fact that we should

50:24be emphasizing

50:26This issue around body mass index

50:28Meaning ie should lose weight, etc. And and I I agree with that

50:33It's really obesity. It's a body mass index is a weird one because like i'm

50:37technically obese

50:38Yeah by the body mass index. Yeah, you and in that sense, you're right. You're

50:42right. It's really about weight

50:44um

50:45the weird thing about

50:47COVID-19 also is the the way it attacks fat cells correct

50:52It can and that can be part of the amplification of this immune response issue

50:56that we work on. Yes, absolutely

50:58That is that really unusual or I mean how much of the factor is obesity?

51:03In terms of just a general uh immune system

51:07Well, I can't say

51:09Again, I i'm not the expert in metabolic disease issues

51:13But we know for a number of conditions that if you have increased weight

51:17Ie body mass index like measures that you are at a higher risk of having

51:23The additional problems because there is from an immunologic standpoint some

51:28activity with fat cells that can surely enhance

51:31An over vigorous immune response and remember with SARS-CoV-2

51:35It's a combination of directly what the virus does to impact you, but also

51:39What does your immune system do? One of the examples? We're all very concerned

§11Transcript · 51:44–57:00

51:44about today is long COVID

51:45And with long COVID it's clear that that is not evidence. It was not evidence

51:50at this point of its ongoing infection

51:52It's not that the virus is still proliferating and you we just haven't gotten

51:56rid of it

51:56So can you explain what long COVID is technically?

51:59You know, I can't and the reasons I can't it's not because I'm not even an

52:03expert because most people can't it's a whole

52:06Series of different conditions the brain fog the fatigue

52:09The cardiac involvement the heart, you know as we see the heart the lungs

52:14And it's not really clear what is going on if you just take a step back

52:20remember before COVID ever existed

52:22We had chronic fatigue syndrome a real condition and people were really

52:26suffering

52:26And when you say chronic fatigue syndrome, is that something you have a test

52:30for?

52:31No, that's the whole point right is that it was kind of a general term a catch-all

52:35That basically covered people and most often it was associated with people who

52:40had had an infectious disease of some kind

52:42Which may have triggered this ongoing immune response

52:46Is there a like a specific infectious disease?

52:49Well, you know epstein-barr virus has been often implicated as being a part of

52:54this picture

52:54But what it's really pointing out is it's really about this ongoing immune

52:59response that we don't yet understand

53:01And I think if there is any area right now that we need

53:05Tremendous efforts put into it's long COVID

53:09You know, there are these new centers starting right now to try to address this

53:12Uh, you know overall we estimate that there may be anywhere from 3 to 10

53:17percent some say as high as 18 to 20 percent of people

53:20Without regard to whether it was serious

53:22COVID they had or milder COVID go on and develop this long COVID

53:26There's an interesting parallel with fighting and I can talk to you about this

53:30with the mma fighters. Yeah that um

53:33Some mma fighters who have had COVID

53:36Particularly ones that didn't I don't know. I don't know. I don't want to speak

53:41that they

53:42I don't want to say that they didn't take it seriously

53:44Maybe they didn't recognize

53:46That they needed to rest more and allow themselves to recover and they trained

53:50through it

53:50And guys that trained through

53:52COVID-19 tended to suffer

53:56Long-term consequences from it there's several examples of this and

54:01After those bouts of COVID-19, there's a thing that happens with fighters

54:06At the very highest level and one of the things that I study with the UFC is

54:10I'm studying like the elite of the elite athletes like championship level

54:15fighters and just a small drop off of performance

54:19Is is is noticeable when they face other elite

54:23Athletes and you're starting to see some of these folks that have had

54:28COVID-19

54:30Then competing and not looking as good

54:34Eight year eight months later a year later post infection and i'm wondering

54:38like what

54:40Is this long cove is this like a milder form of long COVID because clearly they're

54:45in shape clearly?

54:46They look great, but when they're competing

54:49They're not. Yeah, maybe some of them are not quite at the level that they used

54:54to be

54:55Well, I think you raised two very important points when you asked me earlier

54:58about risk of going on and developing

55:00COVID and what the long-term impact may be here. You got some of the finest fit

55:05people in the world

55:06So there that's why I brought it up. Yeah, I know I think the issue around the

55:10immune response in the host and things like

55:13Inflammation, you know the fact that the you can actually find that

55:18That your body's ongoing activity and we've seen this with people who again

55:21this chronic fatigue with chronic lyme disease

55:23People have talked about this kind of same concept

55:26And we really I think are at the

55:29Opening of what I think will be a huge huge

55:33Effort to really look more at the long-term impact of immune response on

55:39something once it gets triggered

55:40Remember our immune system is like skating on a razor blade

55:43You want to make sure anything that shouldn't be there shouldn't be there

55:47But you want to protect everything you can that's yours and you don't want

55:51anything to happen to it bad

55:53And where that really gets interesting is for example in pregnancy

55:56Where you know that fetus is not totally all that mother

55:59But at the same time the body is working to protect that more than it's done

56:03anything ever to make sure nothing bad happens to it

56:05And when that

56:07Disregulation occurs where the immune system tips a little bit more on one side

56:11or the other

56:12You can see ongoing problems and I think that's what this virus is doing

56:16It's it's creating this environment where this ongoing immune response is

56:20occurring

56:21And I think you're going and it's not just one thing

56:24It's a series of different issues

56:26But I think the most important message is is if anybody listening to this

56:30Effort here is that

56:32There is people there are people right now working on this and that this is not

56:37something you have to live with

56:39Hopefully forever looking at drugs treatments

56:41What can we do to deal with long covid but right now?

56:44It's a daunting challenge and I think the example you just gave very well could

56:48possibly be a part of a long covid picture

56:51Now long covid as described

56:54As the way the way we're talking about it is essentially people that feel like

56:58they're not the same now

§12Transcript · 57:00–1:02:31

57:00As they were before the virus they never have recovered fully is that a fair

57:05way

57:05I think it's it's really where they were damaged. Yeah, it's really important

57:09to distinguish if you've spent

57:11The last three and a half to five weeks in an intensive care unit

57:15I don't care whether it was for an automobile accident or it was for covid

57:19You have a long-term recovery in at hand and it's going to take a while before

57:25you begin to feel like yourself again

57:28You know what will happen so you have to distinguish that

57:31Which is not necessarily you can't get long covid that way, but you also would

57:35just have that no matter what

57:37Where it's really becomes very clear is people who've had milder covid

57:42Who then in the second or third week thinking they're getting better all of a

57:46sudden start feeling tired

57:48They feel like they can forget things they're feeling this brain fog

57:52And that's where it's really most noticeable because these were people whose

57:57bodies were not quote unquote

57:59Insulted in such a way with covid to have been bedridden for days and weeks and

58:04you know trying to recover from that

58:06And I think that's the one example where you can say it's clear that there is a

58:11Aftermath of this covid for which some people experience and some don't I mean,

58:16I know many people who have

58:18Fully recovered from covid and you know, they are doing perfectly fine

58:22Now so you're saying some people with mild covid still show some sort of a

58:28decrease in in

58:29Their physical response like their yeah

58:32I've actually know of people who

58:35Had milder covid and they'll tell you that their long code was much more severe

58:39than when they had the acute infection

58:42But what do they mean by that like meaning meaning when I had covid itself?

58:46I was test positive I was tired, you know, but I was kind of around the house

58:51and you know

58:51Not feeling that bad now here. I am eight to ten weeks out and I some days feel

58:55like I can't get out of bed

58:57So something happened

59:00And do we know is it measurable is this like can you get a ekg is there there's

59:07something you can show

59:08And do they have a higher resting heart rate all of those things all those come

59:13to play?

59:14And that's what these new centers that have been set up are actually studying

59:17Is there a mechanism that can explain this or is it a series of mechanisms?

59:23Why do some people have more cardiac and lung involvement other people have

59:27more brain fog, you know, where clearly neurologically something is happening?

59:30You know, why do some people feel such severe fatigue and others don't?

59:34So one of the things is there's not a hallmark of long covid that just says if

59:39you have this symptom this symptom and this symptom you have long covid

59:42It's a combination of different conditions that are happening to people

59:47And are there any methods that they're utilizing that seem to be effective in

59:51treating people that have this?

59:53At this point, we're just in the infancy of that and that's as I said just a

59:57moment ago

59:58This is going to be a critical part of our ongoing efforts with covid is just

60:03the study of and trying to understand what's happening

60:06First of all, as you pointed out, we have to know why you're having these

60:09findings what's going on

60:11And then once we do that, what can you do about it?

60:14what kind of treatments could be effective and giving people hope because i've

60:18seen people who at 12 months after their covid infection

60:22Who are feeling like they've kind of lost their life. They don't have the

60:25energy to go to work. They don't have the energy to be with family

60:29And this this is really a challenge

60:33And um have you read anything about hyperbaric therapy in relation to recovery

60:39from this?

60:40I haven't you haven't no

60:42Have you read anything about is there anything else that stands out like stem

60:46cells or anything that they seem to think would be effective?

60:49I think right now

60:50It's in that stage of just trying to define what it is

60:53You know before they can even know necessarily the interventions that they can

60:57look at. You know, what are the markers?

60:59How is your immune system operating? Do you have evidence of certain immune

61:03markers that are elevated?

61:04You know, why might you have

61:07Some evidence of some heart involvement or your lung involvement so part of it

61:11is right now

61:12Just taking very seriously that long covid really exists

61:15And that we're trying to figure out first and foremost

61:18What might be the mechanisms that are causing it and then I think you're going

61:21to see

61:22A large number of efforts trying to address treatment itself

61:27So it's still ongoing still ongoing absolutely and

61:30You know, one of the things that's going to be a challenge is to find out

61:33How many of the people who had omicron even in their mildest stages that go on

61:37and develop long covid?

61:38We don't know that yet. It's such a strange term long covid. I know yeah

61:42Because it's like you don't really have covid your your covid is done, but you

61:46have the deterioration

61:48Of your your physical abilities. Yes. Yeah, very strange, right?

61:53Well, you know, we saw it again as I said with chronic fatigue syndrome, you

61:57know, that's a term that many people have

61:59Had to suffer with for years and years and years

62:02And you know, we didn't have the major research initiatives around that that I

62:07think

62:07Covid now is drawing the resources towards and hopefully

62:12You know people who have that condition also can be helped by learning. What

62:18what did covid do? Why did covid cause this?

62:20um are there any

62:23I know there's some new

62:25Treatments that are on the horizon that merck has and that pfizer has there's a

62:30bunch of different

§13Transcript · 1:02:31–1:07:43

62:31Antiviral medications and pills that they're putting forth. Is there anything

62:35else that's I think there's also isn't there an attenuated

62:39vaccine an attenuated form of the virus

62:42Yeah, well, first of all, let me just say I think the treatment area right now

62:46is

62:46A very exciting time in development

62:50You know, I look back to my work in the early 1980s and hiv/aids

62:55And at that time a diagnosis of hiv was a death sentence simply a death

63:01sentence

63:01And with the emergence of drug therapies even in the absence of a vaccine

63:06We've taken hiv for many people to a managed chronic disease

63:11And I think that you know, as we look at the vaccines it's clear

63:16We have challenges with waning immunity. How well will they work? How many

63:20booster doses can you give?

63:22Et cetera, and so vaccines remain really the foundational response for dealing

63:28with covid

63:29But I think the drug therapies are going to become really really critical

63:32And we're learning more. I mean, for example

63:35I know a topic that you have been of interest about and the show that ivermectin

63:40You know, there are five big trials going on right now

63:43They're going to be announced results in the next weeks to months

63:47That really have looked carefully at ivermectin including high dose ivermectin

63:51And you know, I've again as a scientist reserved judgment

63:55You know, I didn't close my mind and say no, yes, whatever

63:58I want the data and we got to have these double-blind placebo-controlled trials

64:01You know studies where neither the investigator or the patient know which they

64:05got

64:05You know, and then objectively find out what's happening

64:08I think there's a whole series of drugs coming down from several companies that

64:14surely have that potential if given very early

64:16And the one you mentioned from pfizer for example

64:19pax lovid

64:20While it has some contraindications with underlying health conditions that

64:24might already exist on a whole

64:26It is really a very very fantastic drug

64:29But the problem we have right now with that is that we have many many places in

64:34this country

64:35We're during the surge of omicron. I couldn't get tested for three four or five

64:38days

64:39Why is that because we just didn't have the testing capacity but doesn't that

64:43see that seems like something that would be much more easily

64:46Well, that's what i'm going to okay. That's exactly you you you you hit my line

64:50for me. Thank you. Okay

64:51Is the fact that we need a comprehensive system with surges

64:57Where in fact when a surge occurs

65:00You can scale up quickly so if I need to get a test done

65:04I can get it done the same day and get a result back the same day and then I

65:08can get into a system

65:09Automatically that makes sure I get these drugs, you know

65:12If you're someone in the community and you know, and and you know one of the

65:15things that I have been so challenged by

65:18Is what this has done by race?

65:20I mean this disease has been cruel

65:23If you look at the number of deaths, you know

65:25If you look at blacks twice as likely to die from covetous whites hispanic 2.3

65:30times as likely to die from covet as whites

65:33American india native american 2.4 times isn't this uh

65:37Hasn't there been correlations drawn between vitamin d deficiency?

65:42There has been some and again

65:43This is another area of study that needs to be done

65:45But I mean if you look at these issues here getting the drugs to those

65:50populations

65:51Okay, what can we do it whatever their risk is so that if you have a community

65:56where I don't have a doc

65:57I don't have one

65:59I don't have access to health care in general, you know, I go to a community

66:02clinic

66:03So what I think this whole issue around drugs the point you just raised is

66:07really highlighting

66:08Is now is the time to address this issue of health disparities and just

66:13generally our health care system?

66:14You know, we have a disease care system a disease care system not a health care

66:18system and by the way

66:19It has been under attack for two years. It's it's it's incredible what's

66:23happened by covet by covet

66:25I mean what it's done to care in general and it was done to our health care

66:28workers, okay

66:29So we need to take a look and step back and say, okay, so what could we do to

66:34improve on that?

66:35We'll keep the vaccines, but we know we're hitting a wall on that

66:38Okay, some people are just not going to get vaccinated no matter how we try to

66:42share the information

66:44But we should be able to get people to understand if you do get sick

66:48These are the drugs that can be helpful. This is how you get them quickly

66:52And try to reduce the hospitalizations of serious illness and deaths and make

66:57this more of a treatable type disease

67:00Like I talked about with HIV and the impact in the communities of color for

67:05example, you know

67:07Will be huge if we could do that and it would improve health care in general

67:11So to me that's one of the things i'm working on right now is trying to

67:14understand surge capacity for testing

67:17Let me give you one last example

67:19I think that helps illustrate this

67:21If you look at the fire departments in the state of minnesota

67:24One of the best well-funded fire departments in the entire state is the minneapolis

67:29st. Paul international airport fire department

67:31And thank god we have them. I support every penny we give them to cap that fire

67:35department going

67:36You know large number of units people well trained we've not had a plane go

67:41down there on the airport itself

§14Transcript · 1:07:43–1:12:34

67:43Since its inception any big plane the two that did went down in south minneapolis

67:48in the 50s and were handled by the

67:50Minneapolis fire department

67:52Well, we pay for that every day because we wouldn't operate that airport

67:55without them

67:56We should be paying for test capacity

67:58So if we have a lull in it, it doesn't mean that everybody gets laid off or we

68:03don't do that

68:04We use them for other things

68:05But as soon as that surge occurs, we could put testing back into place

68:09So everybody can get a test that first day and I don't care where they live

68:13I don't care who they are they can get on those drugs and joe we could do so

68:17much

68:18To reduce if not eliminate the serious illnesses hospitalizations and deaths

68:24just with that alone

68:24Just with testing just testing and then the drug availability the drugs you

68:28just talked about

68:29I mean, I think we're going to see more and more drugs become available that I

68:33think are going to have real positive impact

68:35So I see this as kind of the silver lining of this

68:39Pandemic is that people are now beginning to do that and we can do that around

68:42the world

68:43If you're knowing about hiv drug distribution, you know some of the most

68:46remarkable improvements in health have been in africa

68:49Where we've been able to distribute these drugs for hiv day in and day out. So

68:54we surely can do this

68:55For a covet like situation. So that's what we need to focus on and that's what

69:00we need as a globe

69:01Global community understand how can we improve testing so that we make sure we

69:05get people on there

69:06And then how can we make certain that they get their drugs now?

69:09You covered a whole bunch of things

69:11So let's start from the beginning first of all you talked about testing now one

69:15of the things that I thought was

69:16Shocking I was watching this

69:19press conference where uh ron de santis was

69:23Addressing the

69:26Claim that they had let a bunch of covid tests expire

69:30And that they were no longer useful and I was like wow, I didn't know covid

69:35tests expired

69:36So they have a shelf life is they do they do why is that?

69:40Because basically the reagents in there can degrade over time and you want to

69:43make sure you have exactly the right one

69:46So they do have a shelf life

69:47So they must be manufactured in accordance to the need and they're going to

69:52have a surplus and then you have to

69:53Abandon those but you have to keep up the supply

69:56Well, and also it's not just surplus, but we do a thing called vendor

69:59management control

70:01So, you know, you basically rotate it in your shelf

70:03So you have a place that says okay, I will help vendor managers product

70:08So i'll make sure that of all the locations out there

70:11Somebody's not sitting on some stuff and others are using more. I'll make sure

70:16that the most

70:17The one closest to outdating gets out there right and the ones that are farthest

70:22back

70:22Basically, I'll hold so that we don't lose and with vendor manage you can do a

70:26lot to actually reduce that problem

70:28So that was the accusation from the florida administration that they hadn't

70:32distributed those things

70:34They could have done that and got them out there before they expired and they

70:37it seemed like they were hoarding them

70:39Yeah, and I and clearly this again is part of that whole testing issue is some

70:43of it's going to be surge capacity

70:45Because there's only so much you can actually put in surplus stock with the

70:49fact that some of it basically will in fact

70:52Expire and so then it's a matter of okay. So what's your surge capacity?

70:56How do you then say I can bring on board and you can't make it at the last

71:00minute?

71:01It's kind of like a fire department that goes out and tries to buy their fire

71:03truck when the 9-1-1

71:04Alarm comes in and so you got to have people ready to go

71:08You have to have manufacturing capacity to go so when you have a surge you can

71:11do that now

71:12Here's the challenge if you believe that omicron is the last of the variants

71:17you believe that covet is done

71:18Why would you invest in that and that's where I come back and say well?

71:22I hope it's the last one, but hopes not a strategy right yet got to be prepared.

71:26What if another

71:27Variant shows up the challenges again. We're going to have the same needs. We're

71:32going to have the same issues ahead

71:34So we're going to have to plan for that. What kind of shelf life do those tests

71:37have?

71:38It varies. I can't tell you test by test, but it

71:43It's it's months, but it's it's not you know years. It's not years. Yeah

71:47Let's go back to vitamin D sure. So when you're talking about how

71:51disproportionate amount of Hispanics and black folks and and and native americans

71:55essentially people with more melanin in their skin

71:58People with more melanin in their skin have traditionally had lower levels of

72:02vitamin D that live in urban areas

72:04Especially in like cold climates where they're covered up

72:07How much of a correlation do you think there is between low levels of vitamin D?

72:12and

72:14And

72:15more severe code infection

72:17Well, I can say that there clearly have been studies done that demonstrate

72:22reduced vitamin D levels in cases coming in into the hospital

72:26It was like 84 percent at one point in time of people in the icu had

72:29Insufficient levels of vitamin D. Yeah, and I can't comment at the question we

72:33have

§15Transcript · 1:12:34–1:17:29

72:34With vitamin D is it a marker for something else meaning people who have

72:39Adequate vitamin D is it because of their behavior what they eat is it because

72:44they have access to access to certain foods etc

72:47What does that mean? And so we still have to figure that out

72:50But vitamin D isn't really like effectively supplemented through food is it?

72:55Well sunlight and some degree food meaning I take something I'm talking about

72:59taking a supplement

73:00You know if you're if you're basically living from paycheck to paycheck

73:04And you're having a hard time just feeding your kids are you as likely to go

73:07buy vitamin D to supplement?

73:09That's what i'm saying

73:10And so it's that kind of issue there

73:12So but I think the point that you're raising here is again

73:15This is another example of what the kind of studies we need to say could that

73:19help improve

73:20You know much like we did with niacin and milk and so forth, you know

73:23Where we basically were able to show that we can get health benefits in some

73:27cases by supplementing food

73:28Don't they supplement vitamin D and milk as well?

73:30Uh to some degree yeah

73:32Well my milk is just a higher level but but I think the point being is exactly

73:36what you're raising is

73:37This is another example of can we have an indirect benefit to the public by

73:42learning this and actually helping people have adequate levels of vitamin D

73:46I think that's critical

73:47But I do want to make one comment on this so because I think this has been

73:50sometimes

73:52Misunderstood about race and the issue of risk for covid and for serious

73:57illness

73:57If you look the real correlation which again is not cause and effect

74:02But is who are the frontline workers who are the people that left largely unprotected

74:06who did the critical service for us?

74:09Even in health care during the course of this pandemic. It was often

74:12You know our communities of color

74:15And people from that community

74:17I could stay home and work in my computer in my office at home

74:21I didn't have to be out and about I didn't have to sit there and confer you

74:24know and have

74:25Close contact with the public and so one of the challenges also is of course

74:30How do we protect these people from a work standpoint?

74:33And that's why getting vaccines to them is really really important and

74:37supporting the issues

74:38And we've seen some really novel ideas probably the most in fact you would find

74:43this interesting

74:44Is the fact that one of the most novel programs?

74:47I've seen has been a new movement among black

74:49Barbers in black stylists who basically work to talk to their clients in their

74:56chairs and who trust people more than your barber

74:58And they talk about all issues of health and it's a program that started out of

75:02the university of maryland

75:03And it's been fascinating of how it's actually having a really positive impact

75:07in health

75:08But they do kind of like what you do talk about all the health issues

75:11I'm confused. So you're saying there's a program to educate barbers to talk to

75:16their clients?

75:17There actually is and then they actually look at the outcome in their clients

75:21And they've been able to demonstrate major increases in people getting

75:25vaccinated

75:26People seeking out screening for cancer issues, etc

75:29Because the barbers use that time when you're sitting in the chair or the

75:33stylist to talk about health

75:34So how are they doing this through seminars like how are they educating these

75:37people?

75:38It's a major program

75:40Dr. Stephen Thomas who heads this up who is just a very creative innovative guy

75:44and it's starting to spread around the country

75:46It's actually one we need to duplicate replicate in other places where you can

75:50actually

75:50Get the message out to help people, you know, where do they where do they hear

75:55it?

75:55You know, well, I heard it in the barber chair. Well, who do you trust more? I

75:57trust my barber

75:58I don't know. Well, I don't have a barber clearly

76:01I kind of was making that the inference when I was talking about this when I

76:07started

76:07But when I did I had a lady cut my hair and she was great, but I wasn't taking

76:11medical advice from her

76:13Yeah, well, you know if she was highly trained she may it may be a good time

76:17for you to listen

76:18Maybe I don't she tell good stories, but you know

76:20So when you're talking about front front line health care workers, one of the

76:26things that

76:27Is a real point of contention is folks that were frontline health care workers

76:33that were infected that recovered and then

76:36They were facing vaccine mandates

76:38What are your thoughts on that? Well, first of all?

76:41I think it's critical that we add in

76:45Previous infection as a dose of vaccine for certain

76:50So why didn't that happen with those still working folks still working it still

76:54working on it?

76:54I know but in the middle of a pandemic when you desperately need

76:58These people that risked their lives in the early days of the pandemic when

77:02there were no vaccines

77:03Well, many of them were infected with covet recovered and had robust immunity

77:09But yet they were fired because they refused to get vaccinated

77:12Well, let me add a little more detail to the story. It's not quite that simple.

77:15It's not you know, it's not and again

77:18I i'm already up front saying I believe that to be considered fully vaccinated

77:23or whatever status you're going to call it

77:25You should at least include previous infection as a dose now

§16Transcript · 1:17:29–1:22:50

77:29I shared with you a few minutes ago that's been very interesting if you look at

77:33either alpha delta or omicron

77:35It mattered which variant it was as to who did better people who clearly had

77:40had previous infection

77:42Or people who had previous infection were vaccinated and across the board

77:47people who were infected had vaccine

77:49Did much better, okay, so infected and then got back and then that got

77:53vaccinated added one more dose on and it really did boost them up

77:58And they if you study that basically as we look at people then who during the

78:03omicron

78:04Surge who got infected and if we the data are actually out there right now

78:09looking at that and in fact

78:12If you look for deaths for example, if you were unvaccinated

78:15Your deaths during this most recent was about 974 per hundred thousand among

78:20people infected, okay?

78:21But if you were fully vaccinated only

78:24And and you got point seven one cases per hundred thousand big drop and then

78:31fully vaccinated with a booster was point zero one zero

78:34Much lower even yet. And this is death. Yeah, this is death. Okay, you're

78:39talking about death from delta

78:41In this case. This is even omicron is omicron, but the point i'm trying to get

78:45at is if you looked at the hurray of these

78:48those who were

78:50Had fact who had previous infection and were

78:53One dose like a boost actually did very well

78:58So i'm willing to count a dose

79:00But let me tell you why I have a problem with health care workers

79:03Who aren't vaccinated and I support health care worker mandates

79:07If you look across the board

79:1099 percent of doctors got vaccinated they did I mean the data are there where

79:15we saw the lesser levels of vaccination were in the technician group

79:19Nurses were not as high as doctors, but were there

79:22And why is that important because we were able to demonstrate particularly with

79:26omicron

79:27A number of outbreaks or ongoing transmission of cases in health care settings

79:32Where it was the health care workers bringing the virus in

79:35And transmitting and where we looked at that we saw data in and there's several

79:40studies coming out very shortly

79:42Looking at people who were hospitalized

79:44Negative upon admission not there for covid who were there at least 10 days and

79:50then got infected and got seriously ill

79:52Well, they had to pick it up in the hospital and there were two sources

79:55basically

79:56Somebody coming in from the outside i.e

79:59Visitors who in most cases didn't exist or health care workers or they got

80:04infected from other patients. Yeah

80:06And that's three right when it comes yeah when it well, it's the outside inside

80:10kind of thing

80:11So when it comes to patients, uh, you know, we often these people were highly

80:15segregated

80:16They were in totally different segments of the hospital health care workers had

80:19to play a role there

80:20So our point in getting health care workers vaccinated is not just to help

80:24protect themselves

80:25But it's also to help protect the patients right but isn't

80:28Isn't it been proven that people that are vaccinated also catch covet and also

80:32spread covet they can absolutely and we should

80:35But but i'll tell you right now that if you were previously infected and you

80:39have that dose

80:40You're going to be much less likely to actually get infected yourself and

80:44spread the virus

80:45That's true. Yep. So it's not just that you're less likely to die

80:49But you're also less likely to get it and spread it. Yes, exactly. By how much

80:52what factor?

80:53Uh, I can't give you the exact data, but it's it's substantial. I don't have it

80:57right in front of me

80:58It's very substantial that you can get protected with that infection and dose

81:02What the debate has often been for health care workers?

81:05They feel like they didn't get credit for that previous don't that previous

81:09infection right and i'm saying they should

81:12So you think that the health care workers who've had a previous infection

81:15should get one dose of a vaccine

81:18Right and I think we should look at that carefully as considering that fully

81:21vaccinated

81:22And do you think that it matters whether it's pfizer or moderna moderna's a stiffer

81:28version of the virus correct or excuse me the vaccine and then johnson and johnson

81:32is different as well, right?

81:34Right it is and right now

81:36Clearly the evidence points to the fact that moderna gives us a bit of a better

81:40Take than we see with pfizer because it's stronger stronger

81:44Now where j and j is interesting and and complicated is the fact that if you

81:49look at its response initially

81:51It's not nearly as high. It's in the 80 low 80 percent level where the mrna

81:57vaccines are in the high, you know mid to high 90s

82:00But if you look over time

82:02The j and j levels don't decrease they actually go up some and the

82:06Actual level of protection for the mrna vaccines will decrease where you see

82:11that waning immunity at

82:12Can you explain that to people that how the difference in the j and j works

82:14because it is an mrna?

82:16It's not yeah

82:17It's what we call an adenovirus platform

82:19It uses that to basically get into the cell to have the cell make basically

82:24The spike protein that you then get your immune response for but it looks like

82:29the

82:29The j and j vaccine may have more positive impact on the thing

82:34We call t cells a type of immune cell then we see with the mrna vaccines again

82:39all emerging new science

82:41We're learning about I think if I had to make a prediction

82:45In the near term meaning, you know six to 12 months from now

§17Transcript · 1:22:50–1:28:12

82:50We very well we're likely talking about the preferred heterologous vaccine

82:55approach

82:56Of using one dose for example something like a j and j and then a dose of mrna

83:01I think that's really a possibility because this is speculative

83:05This isn't speculative this is based on on more and more data

83:08We're seeing accumulate that that may really be a possibility

83:10And in fact, it's also in this issue that I happen to have an intense personal

83:16issues because our center

83:17The cidrep center for infectious research and policy at the university of minnesota

83:21is actually going to be leading and we announced very shortly

83:25What we call a pan-coronavirus vaccine roadmap process

83:30We just completed a two-year

83:32effort to come up with a

83:34detailed roadmap for how to get new and better flu vaccines all the way from

83:38research and development to marketing licensure etc

83:42And we're trying to get new and better flu vaccines and we're working on that

83:45I think you're going to see version 2.0 3.0 and 4.0 of the vaccines in the next

83:51few years

83:52The vaccines we have now, you know are remarkable tools, but they're not

83:56perfect

83:56And I think you're going to see an evolution just like with drug treatment

84:01Better and better vaccines coming out over the long term

84:05One of the things that I read was that one of the problems with

84:08Accepting natural immunity due to previous infection is that different people

84:16had

84:16Different levels of the disease and that some of those very mild infections did

84:23not impart enough

84:24of an antibody response

84:27And that these people were not as protected as maybe they thought they were

84:31because even though they had tested positive for covid

84:34They they really didn't have that much of an impact on their immune system. Is

84:38that yeah?

84:38Yeah, no, I that's an important point

84:40But let me just add a qualifier to that

84:42When we talk about measuring antibody

84:45I don't know what we're doing and what I mean by that is is that we don't

84:49really have a corridor protection today

84:51There's different kinds of antibody. There's neutralizing antibody. There's

84:54total antibody. Okay, all these different kinds of antibody

84:57There's there's the different kinds of t-cells

84:59And what we're doing is taking one test and saying how high is this here?

85:03Well, does it really correlate with protection and this is what we call a

85:07correlative protection

85:08So for example, I can tell you if you get a measles vaccine and I do a blood

85:12sample on you

85:13I can tell you likely if you have the immune response that's going to protect

85:17you against measles

85:18I don't know what a protective level is here

85:21So when I talk about it, I know that that work is going on and I think you're

85:25going to hear a lot more about correlates of protection in the months ahead

85:29But i'm looking at just from practical experience if you've had covet before

85:33are you protected or not when you are exposed again

85:36And compare those who were vaccinated after having had one episode those who

85:42only had an episode and those who had nothing

85:44And then let's follow them forward and that's where the real proof in the

85:47pudding is is that do they get clinically ill or not?

85:50Do they get infected?

85:52And that's where we're showing right now that I can't distinguish people who've

85:56had a really severe case of covet versus those who have had milder cases of

86:00covet

86:00Maybe over time that will emerge clearly the antibody levels are different as

86:04you pointed out

86:05They are but I don't know how that responds to protection interesting

86:09So just because antibody levels are high doesn't necessarily correlate with

86:14superior protection at this point

86:16We can't say that what we can say is it's likely you have more

86:20But it's a combination of all the parts of the immune system

86:23You know the b cells and the t cells and this is where I mean if I always

86:28jokingly say

86:29You know if you really want to talk about something complicated hell rocket

86:33science is easy it's immunology you want to know science

86:37It's immunology, okay, because this whole immune system we have is so

86:41complicated, right?

86:42And so to me the science you're going to see coming out

86:45Of the immunity related to covet is going to I think bring us some really

86:51exciting developments

86:52HIV aids did that in the 80s and 90s we learned a lot about the human immune

86:56system

86:57I think this is the next best opportunity here

87:00We're going to learn so much about human immunity from just trying to

87:03understand how to protect against covet and how to respond to long covet

87:07so immunity as a whole is a very comprehensive and

87:12Wide-ranging thing right because it's immunity to all sorts of different

87:18diseases and viruses and

87:20Do you anticipate in the future that we can figure out how to boost over all

87:26immunity?

87:27So it wouldn't just be immunity to covet but immunity to flu immunity to all

87:32these different things

87:33common cold like that

87:35Sometime we could get a grasp of the immune system to the point where we could

87:40elevate

87:40The earlier levels of immunity for all infectious diseases. Well

87:45Let me just add that that's a really plus minus situation and what I mean by

87:52that is is that

87:52There really isn't a term natural immunity everybody uses it. So you're in good

87:56company. Okay, sorry, but no you're in good company

87:59But if you go to any textbook of immunology or anything in epidemiology

88:02There's no term natural immunity immunity is immunity

88:05It doesn't matter whether you get it from actually being exposed to the virus

88:09or you get it exposed to the vaccine how your immune response

§18Transcript · 1:28:12–1:33:22

88:12Happens is it happens

88:14But there is another kind of immunity called innate immunity

88:17And that's where if today I get a sliver in my finger

88:21Okay, if there's bacteria all over that sliver and i'm starting to get an

88:24infection

88:25There are cells in my body that don't recognize

88:28That anything other than this shouldn't be there and it responds

88:32Now they're not very effective overall. What you want is the very effective

88:37specific they recognize that bacteria

88:39So, you know, if I get an infection with something the immune response is i'm

88:44going after that specific

88:46Part of that virus because i've been trained to do that

88:50So when you say about boosting the whole immunity you got to be very careful

88:54because

88:55Again, what we don't want to do is cause an immune related disease like the

88:59trigger that might be happening with covid to up

89:02All the immune system in a way that causes you to have this over vigorous

89:05immune response

89:06So I think you're going to always come back to the specific

89:11Antigen or the specific piece of a virus or a bacteria

89:15That you're going to want to go after and you're not going to have one kind of

89:19monolithic vaccine

89:21Because that will elevate everything which could trigger these

89:24Bad things and it won't necessarily give you the specific lock and key with

89:30that fun virus

89:31And so I I can't say I see that overall boost

89:34What I do see though is more work on how do you handle so many different

89:38infectious agents

89:40Or for that matter, I think the one of the areas you're going to see a lot of

89:43work coming out in the near term is on cancer

89:46Cancer vaccines I think have a huge future because you can detect those cells

89:52that are just starting to emerge that are cancerous

89:54Let your immune system clear them out

89:56So what kind of work is being done right now on cancer vaccines?

89:59Oh a lot a lot of work

90:00How does that how would was it an mrna platform?

90:02Well, that's you know how mrna's got all their initial research effort was for

90:07cancer vaccines

90:08Was that's how the first real efforts were put into place by the nih on these

90:13vaccines

90:14And I think that one of the things particularly for people who have specific

90:17risk factors

90:18You know genetically they're predisposed to breast cancer

90:20They're predisposed these things if you could pick up certain changes in the

90:25cells

90:25That indicate this is a pre-cancerous cell or an early cancer cell

90:30Imagine if you had a specific

90:32You know kind of police officer in your body that could help

90:36Identify that and take it out

90:38So a general immune system response is not enough it has to be a specific

90:42immune system response for something that you're looking for

90:44To make it most effective right it most yeah

90:47Is there anything that's being developed that works as like a general immune

90:50system response that enhances general immune system?

90:53You know, I can't say other than just being healthy. I mean if you malnutrition

90:59is a good example where

91:01Basically, you know, you really have a major compromise on your immune system

91:06You know, that's a real challenge, you know stress has been shown to challenge

91:10your immune system

91:11And so I think it's general things like that again. I'm not an immunologist

91:16But i'm curious for my own self if nothing else, you know what you can do that

91:20way

91:20So I think those are the issues that that right now. There's not one thing

91:24When you look at

91:28These cancer

91:30Vaccines, how far off are they from being deployed?

91:34Well, it's not somebody in the cancer area, but only familiar with the work is

91:38going on

91:38You know from my colleagues in the cancer side of the house. They seem

91:42You know, it's still early, but it surely has a potential future

91:47Now when it comes to the side effects and and adverse effects from vaccines,

91:53what is causing that?

91:54Well again, uh, we don't completely know but for example

91:59The myocarditis piece has come up over and over again is likely an immune

92:03response that's occurring

92:04Okay, that it in itself is causing this immune response to attack part of your

92:09heart muscle

92:10What part of the vaccine is causing that immune response?

92:15Well, that's what's not clear yet because it's uh, when I say it's not clear,

92:18you know, it it it's not just a spike protein

92:21Obviously because that in fact is you know, a lot of people have that response

92:25to that

92:26And so I can't say again not being a clinician immunologist

92:30I can say though that

92:31You know when you look at the seriousness right now of myocarditis my job is to

92:35try to figure out

92:36Well, is this is this really a deterrent to getting vaccinated?

92:40And you know, we can show time and time again right now from study after study

92:44That in fact, the risk of myocarditis is greater in getting covet by far than

92:50it is to getting the vaccine

92:51Much greater isn't that different though with different ages and also with

92:55different vaccines like

92:57Hasn't it been shown that particularly for young boys the moderna vaccine is

93:02more problematic than the fires are one absolutely it has been

93:05Yes, it has been absolutely

93:07And isn't

93:09Isn't it shown that with the moderna in particular that there's more of a

93:13chance of myocarditis from the vaccine than it is from the virus?

93:16No, actually at this point that's where we were looking at the you know, it's

93:20it's it may be close to a trade-off there

§19Transcript · 1:33:22–1:38:38

93:22But you don't take into account pericarditis

93:25You don't take into account arrhythmias all the other things that the virus

93:29does to the heart

93:30Which we never talk about and those are actually very substantial and are as

93:34much of a burden in many cases as myocarditis

93:36So you have to factor in what does cova do to your heart?

93:41What does the vaccine do to your heart does their vaccine?

93:45Cause any pericarditis or none. We've done zero zero cases zero cases pericarditis

93:51very zero cases of arrhythmias

93:52But the virus does it zero zero

93:56That's wild. Um, yeah

93:58I have a friend who was a very healthy guy who wound up getting some strange

94:03heart condition from the virus

94:05And he was shocked and one of the reasons why he avoided the vaccine because he's

94:10worried about a heart condition

94:11Yeah, and then he wound up getting a heart condition

94:14From uh, the virus itself now. What what causes?

94:18This response in the heart tissue because myocarditis is an inflammation of the

94:24muscle

94:25In the heart. Like what is causing that from the virus?

94:28I don't know really. I don't know

94:30I mean, this is ongoing studies right now looking carefully at that

94:34Um, and it's surely a major area of study right now, but I don't know

94:39Is there any understanding of what could be done to prevent it?

94:44Is there anything that like when someone is infected

94:48That it shows that certain nutrients or certain medications have been known to

94:53impart some protection from that?

94:56You know, I i'm not aware of any nutrient issues, but I want to point out just

94:59so people are aware

95:00if you look at

95:03the

95:04serious outcomes of particularly vaccines

95:06There are only two cases of myocarditis that are currently under investigation

95:11that caused fatal outcomes

95:13out of all the millions of doses of vaccine 193 million doses they've looked at

95:18in these age groups

95:19And so there's only two two two under currently under investigation

95:23But does that mean that there's only two instances or two instances where

95:27people have died or

95:28Studying well studying in the sense that we know about when I say study they

95:32haven't even yet confirmed that that really is caused by the

95:35Vaccine is being looked at right now. We're more clear on the thrombosis from

95:40the j and j the blood clot issue that clearly caused that

95:43Again inflammation why how the inflammation occurred why it occurred?

95:48I can't comment. We I don't know but I can tell you that even there if you look

95:53at those it's still

95:55From the j and j perspective the risk of a bad outcome with your heart or if

96:00you're basically the thrombosis is still greater

96:03overall from getting the disease

96:06Now at this point the j and j vaccine has had a warning put on it a black label

96:10warning about the fact of thrombosis

96:12Which I think is important but as we have shown over and over again data wise

96:17particularly in many parts of the world

96:19The j and j vaccine is a real advantage vaccine because of the lower dosage the

96:24more stability of it

96:25And the fact that overall the health benefits going to be much greater than not

96:28having the vaccine

96:29Didn't I read something that was pointing to the potential?

96:34Ceasing of the production of the j and j vaccine. Yeah, they did but uh

96:39It was in part and I don't have primary knowledge of this that they actually

96:44had enough inventory

96:45That they didn't want to have outdating kinds of things happen. So my

96:49understanding is not

96:51Permanently shut down. Oh, it's not a holiday. They have a surplus. They have

96:54quite a surplus and so they had more than enough

96:57But they're putting the vaccine out and and they will continue to make it. It's

97:01not they're down and it's uh

97:02And they continue to distribute it is is it still a one dose or are they

97:06thinking of it as a two dose?

97:08One dose with the what they call a booster

97:10Right. Yeah, why do they call it a booster? I mean if it's I hate I don't like

97:14the term

97:14Yeah, I've been really opposed to that from the get-go you know in august of

97:18last year

97:19I was one of several people who came forward and said look at the waning

97:22immunity data

97:23It's clear that at five to six months out

97:26We're seeing an increasing number of people who previously before were seen

97:30protected who are now getting infected who are getting

97:32Seriously ill and hospitalized

97:35And it's because it tends to wane at four to six months

97:39So I very strongly urge that in fact everyone get that that time they called it

97:43the booster dose

97:44I think cdc should change the definition of fully vaccinated for the rm rna

97:50vaccines to three doses

97:52Skip the booster concept for the j and j two doses

97:56And then for those who are immune compromised. They surely should get a fourth

98:01dose. Absolutely. They should get a fourth dose

98:03The data we have says that that does boost even better. You know it

98:07successfully there

98:08But I think that right now

98:10We should be labeling

98:12People with three doses and don't call it a booster. What do you think is going

98:16on with israel?

98:17Well, israel actually is

98:20A very interesting situation in that it is both

98:24The best of science and the worst of times and what I mean by that is they only

98:29have a segment of their population vaccinated

98:31They have a relatively high percentage not vaccinated

98:34Well, I thought they were one of the most vaccinated countries in the world

§20Transcript · 1:38:38–1:43:55

98:38Well, they are among the vaccinated

98:40That's the whole point. They are actually where they're now doing fourth doses

98:43among many people

98:44But if you look at the recent big uptick in cases, they had it was almost all

98:50in unvaccinated people

98:51I don't that's not what I read

98:52I read this whole thing about vaccinated people in israel

98:56Like that there was a giant surge of vaccinated people

98:59No, the surge is primarily in and I don't have the numbers in front of me

99:04But the surge is primarily in unvaccinated people

99:06There surely was an increase in cases in in vaccinated people who had had three

99:12doses

99:13That's why they went to four doses for older populations, etc. But the real

99:18burden the the major thrust in this surge

99:20in israel was in fact unvaccinated people

99:23That's confusing to me because i'm almost positive that I read something that

99:27was talking about the confusion that they're having

99:30Because the amount of vaccinated people that have been infected with covet and

99:34that it's a giant percentage

99:35Of the cases I didn't read anything about it being primarily unvaccinated

99:41people

99:41I just did that see if we can find something yeah, go ahead. I just did that in

99:45my own podcast by the way

99:46Okay, I just did a cover. I covered that about two weeks ago

99:49I actually had the numbers in front of me and actually went through what

99:52percentage were unvaccinated what percentage were vaccinated

99:55Clearly the unvaccinated the vaccinated did see increased numbers of cases, but

100:00the surge was really covered by the unvaccinated

100:03So there's an enormous surge, but it's because of unvaccinated people. Yes

100:09You can look it up

100:11See that is so confusing to me because I was almost positive that read that an

100:15enormous percentage

100:17Like a very high percentage of the people that were new cases that were

100:22infected with covet were vaccinated

100:25They were increased but again the big surge itself and particularly in hospitalizations

100:30and deaths were unvaccinated people

100:32We can get it here looked up here. Yeah, we're gonna find it. See whatever you

100:37can find jamie

100:39You got anything

100:41Sorta sort of I mean

100:43I think it gets

100:45Here's the first thing I found which I don't know like the

100:47efficacy of the analysis of covet vaccine breakthrough infections in highly

100:52vaccinated israel

100:53Okay, recent study published in uh, what does that say? med rx iv

100:58Preprint server research has evaluated model age structured cases of severe

101:03acute respiratory syndrome coronavirus 2

101:06Um vaccination coverage and breakthrough infections to do this the researchers

101:10data ministry of health

101:12I don't know if this is an older piece

101:14Yeah, this doesn't give it to you. This is january 13. Yeah, but I mean it's in

101:18terms of the omicron surgery

101:19There's more data that's come out on that issue, right, but this is only a

101:22month old. Yeah, I know, but

101:24If you look here, uh, I guess google then unfortunately my research assistant's

101:28outside the door. He actually has the papers in hand

101:30So well, let's see what we'll get you we'll get you the data and show you that.

101:36Okay

101:36Uh, and that you can take a look at that. Uh

101:39That's highly that's an old one. That's an old one. That's an old one. Okay.

101:44Yeah

101:44Yeah, you got to have what's in that first let's go to that january one and see

101:47what it says though

101:48Yeah, like it is an analysis and we only looked at the top about the study

101:52Yeah, the following data sources received. Okay, march 21st to november 6 2021

102:00Proportions of the various types of variants and concerns were also confirmed

102:02throughout the course of the study

102:04The vaccinated class divided into five stages to mimic the diminishing of see

102:09these are all vaccinated people

102:10This is not the unvaccinated so you have what we're looking for data that will

102:15actually talk about the number of unvaccinated

102:17So what this study is doing is an important study. What it's looking at is

102:21among the vaccinated

102:22breakthroughs, right? Okay, so maybe we can google what percentage of people

102:28that have covid in israel

102:30are vaccinated covid omicron

102:32Okay, so omicron, which is uh, the mo how much more infectious is omicron than

102:37Then um, the the alpha variant of the delta variant. Well, it's estimated to be

102:43at least two to three times more infectious than delta and delta

102:46was two to three times more infectious than alpha

102:48I had heard it was way more infectious than that. Yeah, that's roughly what we've

102:53got. Just guesswork. Well, two to three is a lot

102:56How do they guess that is like is it dependent on it's a scale based on say if

103:01you're infected how many people you'll infect?

103:04Yeah, how many it look look at households and

103:06Drug contacts that look at that and that's really the primary way to get it

103:12There's not a way you can like look at the actual virus itself and say oh, this

103:16is like

103:17Measurably more infectious. So it's basically in how many people it infects.

103:22Yeah, that's it

103:23It's a real experience. So what happens with it and in the same setting between

103:27the different variants. What does it mean?

103:29You got anything

103:32The first thing I found what it was blocked, but it said before blocked said

103:37that 40% of the population is rules and on and is unvaccinated

103:40Yep, but 40% yep again

103:43Why did I see like I read that it was 80% that were vaccinated?

103:48Uh, is that true? No, that's right. That's exactly what that's exactly and that's

103:51the group that really had to click on this

103:53It's gonna disappear real quick. See, it said it. Yeah, sorry

§21Transcript · 1:43:55–1:49:08

103:55You got you have the right stuff to find that is the right piece

103:58Yeah, I can get it. Yeah, I have thing

104:00So, but anyway, I think the message I think that is only got 60% of their

104:06population vaccinated

104:07Yeah, I thought it was way higher than that

104:10No, so I think the message though lags behind on code 40% of israelis have no

104:14protection against covet

104:16Yeah, but isn't that oh, it's omicron variant. It says yeah, right

104:20But how does that work then? I mean, right is is that because omicron evades

104:23the protection of the original vaccine?

104:25It does and it also evades the previous infection

104:30But is that like put that article up again?

104:32The way they're phrasing that is that a manipulation of language because if

104:37saying 40% of israelis have no protection against covet omicron variant

104:42But are they vaccinated from the original variant?

104:45Because if they're saying that they don't have any protection are they saying

104:49that because

104:51They don't have protection because they've not they don't have antibodies for

104:56it. Are they saying they haven't been vaccinated?

104:58I can't tell you what that headline is saying there all like it's weird though,

105:01right?

105:02All i'm telling you is is that if you look at the proportion had no vaccine

105:06those that had full vaccination, but no booster

105:09That's what they were trying to compare. So this is what that is what they're

105:12saying

105:13So look it says 1 million refuse the booster. Yep

105:16While just 110 000 out of 1.2 million young kids got the that's a lot of

105:20language there

105:21Yeah, I recently found something when I was looking that said that uh, this is

105:24back in the end of the summer that 90

105:25Enough doses had been administered in israel to get 99.3 percent of the

105:30population vaccinated

105:31Yeah, that's enough to but doesn't mean that they were

105:34It's also because they also counted a dose to person and if you get two and

105:40three doses you take it away from somebody else

105:42So merely having 100 million doses and 100 million people doesn't mean you have

105:46100 million people vaccinated

105:47Well, they also don't count you being vaccinated if you're not boosted

105:51Well, they do but they don't count it as fully vaccinated

105:55Right, yeah, but you have they have a green card situation or yeah, yeah,

105:59whatever they what is that?

106:00What's their term that they use? I don't know what it is

106:02So with them you have you must be boosted to be termed fully vaccinated correct,

106:08right?

106:08So when looking this is what pops up

106:10For what percentage is vaccinated?

106:14But like it's enough to have vaccinated 99% of the country's population, but it

106:19doesn't mean that they did it exactly

106:20Okay, so you said that

106:22Omicron so part of the thing the reason why that article was phrased that way

106:28is because omicron

106:29Evades the protection of the vaccine

106:32It does evade protection of vaccine and it evades

106:35the

106:37Protection from previous infection at a level that the other variants hasn't

106:40done if that's the case

106:42Then what is the benefit of getting vaccinated now?

106:45Well, there's still very substantial protection

106:47But if it's evading the protection of the vaccine, what is the protection it

106:53gives you?

106:53Well, again, let me point out these are numbers I said before if you just look

106:57in this country

106:58for the issue of

107:00This is during omicron

107:02If you look at deaths again, the point I made earlier if you're unvaccinated

107:06Your rate is about 9.74 per 100,000 population 9.74 if you're fully vaccinated,

107:13it's 0.71

107:14But if you're fully vaccinated with a booster, it's 0.01 per 100,000

107:20But how is that possible if it evades protection of the vaccine?

107:25If you said a hundred percent of all the cases that nearly a hundred percent

107:29are now omicron

107:30But omicron evades the protection of the vaccine

107:34But not for everyone. It reduces it. So what we're talking about

107:37It reduces the protection of the vaccine?

107:39Yeah, so for example with the booster you can boost it back up if you look at

107:43For example fully vaccinated two doses or you look at it versus two doses plus

107:49what some would call the booster

107:51You had eight times as much protection with full vaccine

107:55And that booster than you did just full vaccine from omicron. Yep. Yep

108:02And how is it not protecting you from the vet? Then how is it evading the the

108:06boot the vaccine?

108:07Well, the evasion is not complete is it is limited

108:11So if you take something from 95% protection to 78% protection, we call that evading

108:16immune protection

108:17But you're still getting substantial protection for most people

108:22So when that's a term that is not very artful to say the main of fusion

108:27Immune evasion doesn't mean that is yes or no. It's like a real stat

108:32And so what we're concerned about is that goes on over time

108:36That immunity may actually continue to lower and lower and lower and that's

108:41what we're trying to study right now

108:42Is we can't boost our way out of this pandemic. Are we going to need vaccines

108:46every six to seven months? We don't know

108:49But that's when I talked about by waning immunity

108:51so

108:53The booster helps something

108:56From omicron it helps you avoid severe illness

109:00Yes

109:02That's what I just gave you just now or deaths

109:04But if you look at hospitalizations

109:06The same thing, okay

§22Transcript · 1:49:08–1:54:11

109:08If you look at these are data from december 25th for the united states for

109:13hospitalizations

109:14And this is gauging like how many people who are admitted were boosted versus

109:18how many people

109:19Only had two shots versus how many people were unvaccinated

109:22Right, and I don't have the data on the boosters for those data here

109:25But if you look at for unvaccinated people for hospitalization, it was about 79.6

109:32per hundred thousand during

109:34Omicron

109:36If you were fully vaccinated, it was only 4.4 per hundred thousand. So 79.6

109:41versus 4.4

109:42If you're boosted it even takes it down lower

109:46And does this factor in comorbidities?

109:48Does this factor in all the things we talked about like low vitamin d obesity?

109:53It's all of it

109:54There's not a distinction made

109:55I haven't seen any breakouts

109:57The best breakouts we get are largely those with age and some of the major comorbidities

110:02And what about previous infection?

110:04How does that factor in with omicron?

110:06In previous infection again also gives you more protection like a dose of

110:11vaccine, but it's not yes or no

110:13It's think of it like a dose of vaccine and that's what it does

110:16Now is there a possibility of an attenuated covid vaccine?

110:24It's possible and in fact, I think many of the vaccine researchers are thinking

110:29what can we get to really cause the upper respiratory protection?

110:33Localized protection in your upper respiratory tract

110:36Because if you can stop the virus there

110:38You can stop it from going deep into your lungs and then going into the rest of

110:41your body

110:43Clearly, people are looking at what vaccines would work and you know

110:47Our previous experience would suggest that live attenuated as you called it,

110:51which is something that actually grows

110:52Causes an immune response, but doesn't cause illness could be one way to go can't

110:57say it

110:57It's going to be the way but it surely is something that everybody's looking at

111:01right now. Is that in development?

111:02Well, I can't say it's uh in

111:05In development in the sense there are several labs working on it research wise,

111:09but

111:09Development might say a little further along, but I think it's going to be the

111:13future

111:13I think it surely could be a big part of the future and when these labs that

111:17are working on it

111:18Have you seen promising data? Have you seen trials?

111:20I haven't at all. It's far too early for that yet

111:23I mean, I think part of the challenge we had

111:26was in

111:28January and

111:29February of last year

111:31We kind of jumped on the

111:33MRNA bandwagon to the extent of saying this was going to be the answer

111:38And some people will say well, you know, we uh, we didn't say it would protect

111:42against

111:43Infection, but there was a sense it was going to really protect against

111:46infection at 95 percent

111:47I think it was only really by this summer that people begin to realize that

111:52they're still very very

111:53Important and remarkable tools, but they're not perfect

111:56You know, these aren't going to necessarily be the final vaccines we need

112:01And so it's really only this summer that you started to see more interest in

112:04well

112:05What other vaccines can we look at? What is going to be 2.0? What's going to be

112:083.0?

112:09And at this point, you know, that really is now people are realizing we do need

112:13much more in the way of vaccine research

112:15That's why I mentioned you our group is actually developing a roadmap

112:19For how do we get these new and better vaccines?

112:21Now, what are your thoughts on the monoclonal antibodies?

112:25Well, I think it's a very powerful tool

112:29I think my concern and we had an article in the sidrap news this week and I

112:33covered it in my podcast this very week

112:35The one that was what's the name of your podcast ostrom update?

112:38It comes out every thursday morning and I actually covered the issue that our

112:43big challenge right now is we're seeing it not being used

112:46You know, even though that we're down to one

112:49monoclonal as you know the other two basically

112:51Because of omicron and the mutations challenging how well they worked

112:56But we're sitting in a number of states right now where we have pexlovid

113:01And monoclonal antibodies not being used. Why is that?

113:05Well, that's the challenge. Is it because people aren't aware? It's because

113:09people can't get tested in time

113:10And so therefore, you know, you have to have it within that five-day period

113:15People actually get sick enough that they move into the hospital quickly and

113:19then therefore they're not eligible for it

113:21Is it because they don't have access in their communities?

113:24I mean if you don't have a health care provider

113:26How the hell do you get tested and get the result back and take it to somebody

113:30that will issue a prescription for that drug?

113:32It seems like if you're trying to

113:34reduce deaths and severe illness

113:37That monoclonal antibodies would be an important part of that strategy should

113:41be absolutely I couldn't agree more now

113:43Why did they eliminate the first versions of monoclonal antibodies?

113:47Well, the first two actually which were quite effective

113:50It turned out that actually the mutations in omicron basically

113:55Cancelled out their effectiveness because the mutations were where those two

114:00monoclonals really attacked the virus

114:02Was it a reduction of protection or elimination of protection?

114:07Well in the laboratory setting it was largely almost an elimination of

§23Transcript · 1:54:11–1:59:26

114:11protection

114:12And uh the challenge we have is is we went through a period where omicron wasn't

114:18everywhere all at once

114:20And some people were concerned about the fact that well, you know, we should

114:23have taken off

114:24The market right away still delta cases because there were still delta cases

114:28and the problem

114:28We had is we just didn't have an adequate way to test people to say you have

114:33delta or you have omicron

114:34Because either one would have made a decision easier to say oh go with this one

114:39or go with these two yet

114:41So that becomes a problem

114:43Again with testing and that and and particularly testing for which variant

114:48people are sick with yep

114:49And and how fast could we get those even if you can't get it for a patient

114:54Can you have a running average of what's happening in your community?

114:58So if you suddenly see that only you know four percent are you know omicron and

115:0496 percent are delta

115:06You're probably going to err on going with the monoclonal that's from for delta

115:09If you see the reverse you're going to say well, it doesn't matter to use those

115:13other two

115:14They're going to be in ineffective. I'm going to use this one

115:16And we don't even have those kind of data in a timely way, which is part of

115:20what I was talking about earlier

115:21We need this national testing

115:23Prioritization we need to really put this in there and that should be part of

115:27it for purposes of treatment

115:29And which monoclonal antibody is most effective for omicron?

115:32Well, it's one that

115:35Actually is made in england. It's not very common here

115:38Trovimab is the name of it that most people wouldn't recognize the name, but it's

115:43one that

115:44Basically, it attacks the virus at a different location to the other two

115:49And that still has been shown to be quite effective. Is that one effective on

115:53delta as well?

115:54I mean yesterday so yeah, it is too. Yeah interesting. Yep

115:58So that would be like an almost universal monoclonal antibody at right now

116:02But tomorrow another variant could show up and it'd be all done. And that's how

116:06it works with this stuff, right? Yeah. Yep. What was

116:09What was unusual about this in terms of early treatment?

116:14This this

116:17This disease is so unique and so different like what do you think could be

116:23learned?

116:24From the way the early treatment of the virus particularly before the vaccines

116:29were administered

116:30You know a lot was learned and you know

116:34I looked to our colleagues in italy to new york a number of places that

116:39The kind of care that they provided whether it was ventilators how they

116:43approached it what they did in terms of oxygen

116:46um

116:48How they helped basically try to regulate what the immune response was or wasn't

116:53and frankly the survivorship of

116:56Patients with similar conditions between those early surges

117:00In 2020 and even six to ten months later was substantially better

117:05The intensive care community did so much so much to try to understand what

117:11should be

117:12The best methods, you know, what what should be our standards of care our our

117:16best practices

117:16And so we have seen a substantial increase in in outcomes for patients just

117:22based on the early research

117:24Do you think that because of our?

117:28Having gone through this pandemic that we are better prepared for another

117:32pandemic like save

117:33COVID was to die off. You don't think so we're in westward shape. Why is that?

117:37500,000 health care workers have quit their jobs in the last two years

117:42I have seen

117:45Battle

117:47Fatigued soldiers who are friends of mine come back from war

117:51With less post-traumatic stress syndrome that you see in the health care

117:54workers

117:55They are we don't have really have a good sense of just how fragile our health

117:59care system is right now

118:00If that's the case, why would they fire so many unvaccinated workers?

118:05Well, you know, they didn't fire so many there was one to two percent at most

118:08one percent a Mayo Clinic. That's really a Mayo Clinic

118:11Fired, uh, you know 700 people out of 70 or excuse me. Yeah

118:16700 people out of 77,000, okay? And again, you have to look at where their jobs

118:21were

118:22Were they in intensive care or not? Were they up front? You know, were they the

118:25people that were at admitting, etc?

118:26So you think that's a false narrative that I think it's absolutely a false

118:29narrative

118:30Unvaccinated health care workers very few of the doctors and nurses who work in

118:34intensive care were unvaccinated

118:35They want to be vaccinated to protect themselves. I mean we've lost 300 health

118:39or excuse me

118:403,000 health care workers have died of COVID since the beginning of the

118:43pandemic

118:44And so they want to be vaccinated largely and as I said 99 percent of doctors

118:50got vaccinated quickly

118:51I think the challenge is we don't understand yet is how fragile our health care

118:57system is

118:57So when you ask me are we better prepared right now?

119:00The Department of Labor has just surveyed health care workers and think that we're

119:05going to see a number of them quitting

119:07In the next three to six months just out of they're burnt out

119:10what could be done to

119:13Strengthen and enlarge the health care system to make it better prepared for

119:19some new pandemic

119:20And what what could be done in terms of having treatment protocols prepared in

§24Transcript · 1:59:26–2:04:35

119:26advance?

119:27We have to be better prepared to handle surge capacity

119:31We just weren't

119:32And this is a term is this hospital beds is this staffing staffing and training

119:37and the problem is

119:38Joe that we've lost so many senior doctors and nurses who are just burnt out

119:43That even though we have the pipeline coming in for medical school

119:48We've had more applications in medical school in the last year than we've had

119:51in many years

119:53but the problem is it takes time to educate them to get them to be in a more

119:57senior status learned status

119:58And so for this period of time right now we're going to have real troubles if

120:02we have another big surge because

120:04It was it was almost like a a vicious cycle

120:08The more people that were infected meant more cases in the hospitals the more

120:13care needed the more care needed

120:15The more people were stretched the more people got stretched working the more

120:18quit the more that quit

120:20meant that the fewer people had that much more work to do again again and again

120:24And that's why in effect it casket and you know

120:27I thought I'd never see this in my lifetime

120:29But all eight of the major health care systems in the state of minnesota

120:33including the mayo clinic

120:34took a full page out ad out in papers around minnesota back during the omicron

120:40surge

120:41Begging people please don't get infected we can't take care of you

120:45We we don't have the quality of care has dropped you know when you were during

120:50this recent omicron surge

120:52You did not want to have a heart attack. You did not want to have an automobile

120:56accident or a stroke

120:57Because of the challenge we saw people literally waiting two days in emergency

121:02rooms

121:02Really? Oh, it's crazy

121:04And it was just a shortage of staff. So equipment wasn't the problem beds weren't

121:09the problem

121:10It's people

121:11And so I think that that's one of the things we have to really invest in right

121:16now if we're going to be prepared for any future search

121:18And what we have to understand is how many health care workers now not just the

121:23stress of what they did

121:24But how many times that they're vilified in the community because they people

121:29say you you know

121:30You didn't do what you should have done to save my loved one's life, etc

121:33And they're doing everything they can

121:36Do you think masks work?

121:39Um, i'll answer that if you can tell me what's what's what's similar between a

121:45747 and a and a

121:47Car

121:49What's similar?

121:50Yeah, they both hold people they both have tires. That's it. Well master like

121:54tires, you know, it's it's they're different

121:56They're totally different

121:58And so whether you have the n95 on that thing that I wore into this studio

122:02Which is a high level protection or you wear a face cloth covering totally

122:06different between night and day how well they work

122:08You know shortly I was after I when I was on here in 2020

122:12I wrote a piece in april 2020 saying this is aerosol transmitted. It's like a

122:16perfume. It's like smoke

122:19And basically you have to have high level respiratory protection to really

122:23protect yourself

122:24And what we get is we got into people saying well anything works and some

122:28studies were done

122:29Which frankly if one of my graduate students had done those studies, I would

122:32have failed them

122:33Because they were so badly done in terms of trying to understand that face

122:37cloth coverings work

122:39Well, they don't they're much more of a clothing

122:41Decoration than they are anything about really working and so when you ask me

122:47Do n95s and kn95s work? I'd say yes

122:52If I say a face cloth covering surgical mask no

122:56And that's a big problem a lot of people are wearing those surgical masks which

123:00are to stop droplets when you're doing surgery, right?

123:03Yeah, and and not only that, but you know

123:05Just on my trip down here, which this is only my second trip in two years

123:10Some of you used to fly 150 000 air miles a year

123:12I can't tell you how many people

123:15Were not wearing masks at all even though it was mandated or they wore them on

123:20their chin. They were chin diapers. That was it

123:22You know, we've been doing a study where we freeze frame news media

123:27Reports and just look at the people in the frame whether indoors or outdoors

123:32We have consistently seen since the beginning of the pandemic a quarter of the

123:36people were under their nose

123:37That's like fixing three of the five screen doors in your submarine. You know,

123:41it doesn't matter. You know, what good does it do?

123:43So explain to me how

123:45N95 masks work if you can breathe out of them

123:49Yeah, if you can breathe into and breathe out of them

123:52What are they doing to protect you from infection?

123:55And what are they doing to protect other people from being infected?

123:58And that is the key issue right there people don't understand the difference

124:02There are two issues that are critically important to protecting you and

124:07protecting others from you

124:09That is fit and filtration

124:12Think about swim goggles. I mean, you know, it's all about fit

124:15You know, if they don't seal completely they leak. Okay, so you got to have

124:19something that's a very tight fit

124:22That means also by the way you can't wear a beard if you wear a beard

124:25You invalidate anything you put in front of your face because it all leaks

124:28right through. Okay

124:29One of the problems we have with kids is we don't have good sizes because n95s

§25Transcript · 2:04:35–2:09:45

124:35as

124:35Basically over the oversight regulation of those comes from the occupational

124:40world

124:41It's largely for professional use and we've never really looked at for personal

124:46use

124:47So I will have to say fit is a challenge. Okay, it absolutely is

124:50But filtration is what's critical and people don't get this the material in an

124:55n95 is a milk blowing material

124:57It's actually it's a what a milk blowing. It's like a foam that hardens. Okay

125:02And it has you saying milk milk. Yeah, that's what they call it. Yep. Just like

125:07that. Yeah

125:07And it is basically one that has large enough spaces in it

125:13That allows air to move through it regularly. Okay, but like a good

125:17Electronic filter you might put in a room it has an electrostatic charge in it

125:22So as the viruses come through they get grabbed quickly

125:26So and this works really well the virus clinics to the outside of the mask

125:31No, it's in actually as it comes in it's outside

125:34But it's on the inside too as the mask. That's why it's like it is

125:38And so this special material is what gives you both the breathability

125:42But also the protection so when you wear a cloth

125:45Even if you can breathe you have no protection the virus will come right

125:49through in and out

125:50Okay, so when you see i'm sure you've probably seen these uh, there's a doctor

125:55who uses a vape pen

125:56And he blows through various masks to show you

126:00The the porous nature of them and he uses a surgical mask and a cloth mask

126:05But he also uses an n95

126:07So you think that that is disingenuous because he's not taking into account the

126:11electrical charge of this mass that actually exactly

126:14You want you want to have it breathable you want to be able to make certain you

126:18have to

126:18That's right. Yeah. Yeah. I jokingly say I could stop all transmission

126:22Let me put cellophane over people's faces, but that wouldn't last very long

126:26And so that's what makes these so really important and so what we need though

126:30is we need a major initiative

126:32To basically develop a personal n95 like material that's comfortable

126:38That people can wear with good fit

126:40And that people can actually breathe through in a way that they'll use them

126:46So the n95 material and it you said it's a milk. What is it milk born blown?

126:53It's basically

126:54It's a type of industrial process where they basically put this material down

126:58And it has the electrostatic charge and it has the porous nature that lets air

127:03move in and out

127:03Now should they be replaced on a regular basis and if so like how regular you

127:08know

127:09Only when they're really soiled or they're not tight fitting tight in your face

127:13You can actually wear them for quite some time. I wear my n95 for days days.

127:18Yeah days

127:19But you should probably have a new one once a week or something if you can that's

127:22great

127:22You know, they run a little over a buck buck 50 some places

127:26And I think the most important thing about them is right now they're readily

127:31available early on in the pandemic

127:33You know all of us said don't use them because health care workers need them

127:36We had a major short supply

127:38But by the summer of 2020 all the manufacturers had so boost production that we

127:43have more than enough right now

127:45So the public can use them they can be very helpful, but you got to use them

127:49And you know wearing it under your nose or not wearing it. I mean I find for

127:53example in schools

127:54The great debate right now is you know, what do we do with masks in schools?

127:58So kids go to class all day

128:00They wear their whatever they're supposed to be wearing then they go to the

128:03lunchroom for half an hour

128:04They take it off while they eat with all their friends. I'm sitting there going

128:08now the virus doesn't take a vacation just when you're at lunch

128:10Okay, so what should they do not eat?

128:12No, but I think you have to at that point then figure out do you need to space

128:16people and just does that work?

128:17Well, basically, it's one other option

128:20I mean in an indoor setting yeah, can you really space people out to the point

128:24where you can

128:24Have sick people in the same room and not

128:28Can't sick affected but then that's where ventilation comes in ventilation is

128:33huge

128:33And what we can do for example in fact

128:36You can actually develop and build and put into schools things called Corsi

128:41boxes

128:42Corsi boxes named after the

128:44The air aeros biologist specialist who devised these are basically taking a

128:50regular fan

128:51And putting in a MERV filter a high level

128:55furnace like filter on one side of it

128:57And basically

129:00Attaching it to the fan and then letting the air blow through the filter

129:03Put one of those or two in a room. You can do a great deal to eliminate virus

129:07Things like that that we haven't thought about things that we need to we should

129:11be investing in the in our ventilation systems in

129:13So many buildings and we're not

129:15Interesting. So the ventilation systems that they have on airplanes

129:19They've been touted as being very highly effective, right?

129:23They can be more effective

129:24But you know, I sat next to a guy yesterday in the plane that took his mask off

129:28most of the time

129:28And it was a surgical mask to begin with, okay

129:31And so I mean if you have enough infected people on a plane

129:34I do believe you get transmission on planes

129:36I don't think you can say that they are absolutely perfectly safe

129:39They are safer clearly by the air filtration how it goes through the filters

129:44that they have and move it around

§26Transcript · 2:09:45–2:14:31

129:45But isn't it kind of nonsense if you're sitting right next to a person and they're

129:48allowed to take their mask off to eat?

129:50Then what is the point of a mask mandate?

129:52Thank you. I agree

129:54So what should you be doing?

129:55You think everybody should be not eating on a plane and just keep up?

129:58Well, you know, I think

130:00Well, first of all, I wrote a piece again not long after I was on here

130:05where I didn't support general lockdowns

130:07I said, you know what?

130:08When you have a surge, apply the brakes

130:12And what you're applying the brakes for is trying to keep people from

130:15overwhelming the health care system

130:17And of course you want people not to become seriously ill and die

130:20But that if you maintain lockdowns as they call them

130:24When you don't have high activity

130:27And we had many parts of Minnesota that

130:29Didn't know of anybody that got infected in greater Minnesota

130:33And yet they went into that

130:35That's a challenge

130:36But when you do see the transmission

130:38Then you want to have that limited time period

130:41Well, I'm the same way with mask mandates

130:43Two things

130:44One, there's a time and a place if you want to try to stop or eliminate

130:47transmission as much as you can

130:49But then also don't make a mandate around somebody wearing a face cloth

130:53covering

130:53You know

130:55Because it doesn't work

130:55It doesn't work

130:56Or a surgical mask

130:57Yeah

130:58And so that is what you see though when you have a mask mandate

131:01You see people wearing what you think are very ineffective masks

131:04And so I continue to come home and say

131:07You know, please wear high quality respiratory protection

131:10Then I can support more mandates for a limited period of time when you have

131:13that surge capacity

131:15I mean what we just went through for the last 10 weeks

131:18Was an example where if the more we could do to slow down transmission like

131:22that

131:23Add in the in the papers in Minnesota from the healthcare systems we're asking

131:27people to do

131:28Just give us a break

131:29I think that's fair

131:30I think you're going to see a period coming up in the next weeks where you know

131:34Whether the public health thinks you should be wearing a mask or not

131:36The governors have already read the tea leaves and said no we're not

131:40And I don't think that's a wrong thing

131:41When you saw the residual effects of lockdowns

131:46Like particularly high suicide rate depression drug addiction

131:51There's a lot of businesses went under a lot of restaurants went under

131:56What do you think could have been done to manage that differently?

131:59And you think that that that residual effect is just a function of not being

132:04prepared and not

132:05Not anticipating anything like this ever happening and not having the steps in

132:09place to handle it

132:11You know, I don't think it's a straightforward issue

132:16What I mean by that is I just saw a recent research

132:18Effort that just showed that the number one reason for depression during the

132:23pandemic

132:23Was not about losing a job or work. It was losing a loved one

132:29And you know when you have 900 000 people die

132:31And it's among the top 10 causes of death for all age groups

132:36When you have 3000 kids or excuse me 300 000 kids in this country 300 000 kids

132:42Who have lost a parent or a guardian who took care of them?

132:47You know, it's that adds to the challenge

132:52So I think that we clearly had an impact by the negative things you just talked

132:57about

132:58But how much was actually caused by quote unquote these mandates and how much

133:02was caused by just going through a pandemic as hell

133:06It's not it's it's tough

133:08Right. It was both though, right?

133:09It was both though. I'm actually acknowledging what i'm saying though is trying

133:12to understand that

133:13Isn't a self-important for going forward because we as I shared earlier in this

133:18Session we could see another surge again. So what are we going to do next time?

133:23How are we going to be prepared for that? How are we going to communicate to

133:26the public?

133:27What are we going to tell them we need to do and why?

133:29And you know right now I think they tune us out quite a bit because they feel

133:34like we don't get it

133:35We're not going to you know, why do you think that is?

133:37One is they're fatigued and tired. I mean think about ebola back in

133:432014-15 it lasted for about four months worldwide

133:47It was over with if you look at the 2009 h1n1 pandemic

133:51It was really about six and a half to nine months and then it was over with we're

133:55now into our third year

133:56fatigue is setting in

133:59I mean if I get asked to run a marathon once that's tough

134:03But if I get asked to do it day after day after day for months and months, you

134:07know, I give up

134:08And so I think that part of the challenge we have with this virus which has

134:12made it so difficult

134:14It's the long-term nature of what's happening and and I'm not saying that that

134:19Excuses any of mistakes that have been made about how to approach it, but it's

134:23just human nature right now

134:25We're challenged. We're tired. We want it done

134:27And so I think that's one thing. I think the second thing though is is that

§27Transcript · 2:14:31–2:19:56

134:31We didn't communicate clearly

134:34What we know and don't know I started out the program by saying that

134:38What do you think was was done incorrectly by what we

134:42By not communicating what we know or don't know?

134:44I think we had

134:48We gave the public expectations that they felt like they

134:51When things changed quickly that we were not credible

134:56You know

134:58Like what for example, you know, a year ago right now, you know, and I'm not

135:03taking any great credit

135:04But you know, I made public statements that I thought the darkest days of the

135:08pandemic were still ahead of us

135:09And it was because of these variants. I didn't understand. Wow. How could they

135:13affect things?

135:14Well, and look what happened

135:15But we had many of the talking heads out there of which I include myself as a

135:20talking head who are saying to the public

135:22You know, it's over with now summer is going to be

135:25Quiet and calm the peak has come down vaccines flowing. Maybe we'll have a

135:30little bit of activity next winter

135:33And then delta came along

135:34Why do you think that they

135:35Made those declarations?

135:38I think

135:39There was a situation where we lacked humility and saying what we know and don't

135:45know

135:46I mean when I leave here today, I hope everyone says

135:48Osterholm says maybe it'll be okay

135:50But maybe it could be another bad one and we got to be prepared for it

135:55You know, it's it's that willingness to say I don't know

135:58I mean, I think probably the three most important words I've said to you all

136:02this entire session is I don't know

136:04You know, and I think that that's what we haven't done enough of and then we

136:09have to tell people

136:09What are we going to do to find out?

136:11What do we need to know, you know to basically answer the question?

136:15Well many of the questions you asked me already

136:17And I think that message is one that we have not done a good job getting out of

136:22just being humble and saying I don't know

136:24But this is what might happen. This is what could happen

136:28Speaking of I don't know did you did was there any more definitive data on israel

136:33or was it too confusing?

136:34I think that the confusion came with

136:40That because I kept seeing that four doses for some people

136:44The confusion meaning what they determine as to being vaccine right yeah, what

136:47yeah what the definition of that word becomes so when we walk out of here

136:51My research assistant is going to tell you exactly the answer. Okay, he's gonna

136:55bring him in here

136:56Go get him if you want we could take a 10 second break

136:59Yeah, we'll take a 10 second break and go get the data. That'll help everybody.

137:02I like that. Thank you

137:03Okay, so to wrap it up

137:06What's your assessment of what we just looked at in terms of like the the israeli

137:12data?

137:13I think the really important message here if you look at the countries

137:16What happens to them in terms of cases?

137:20Severe illnesses hospitalizations deaths it's vaccine vaccine vaccine

137:25Good example, but is it true?

137:28Is it 90% of the population of israel have at least two doses of the vaccine?

137:33Yes, the data we have shows that but the right of it

137:36That was what we know

137:37I'm talking about the fact if you look at the surge is could being contributed

137:41by those people who are unvaccinated

137:43Completely unvaccinated and well, we have a number of them that have one shot

137:48Which is not nearly enough adequate protection unless it's the j and j

137:53No, that's even people who have gotten

137:56mRNA but just got one shot we still see that in the in here in the united

138:00states

138:00Right, but i'm saying it's the j and j count as like a one shot because one

138:04shot is fully vaccinated with the j and j until

138:07I can't I don't know in israel how much j and j was used

138:11I don't know so your thought is the reason why

138:14Everything's going sideways in israel is not the failing of the protection of

138:20the vaccine

138:21But rather the fact that there is a substantial portion of the population that's

138:25unvaccinated it's both

138:27But what i'm saying is what really brought that surge on was in terms of

138:31hospitalizations severe illness and deaths

138:33Was largely of that surge piece was among unvaccinated or one with one dose

138:39Okay, so it's one dose or zero doses. It's not two doses not two doses

138:44So when you hear about vaccinated people catching covid in israel

138:50It's a small percentage

138:52Small percentage of what of their population that has covid

138:58No, actually it well, I shouldn't say small. Yeah, it is relative

139:02But if you look at the total numbers, we also did see infections

139:06Among people who were fully vaccinated. Yeah, what we're talking about and I

139:11talked about that surge

139:12I'm talking about it in terms of severe illness hospitalizations and deaths and

139:15that was being driven

139:17Largely by those who are unvaccinated or who had just a single dose

139:23And that's what those data show

139:25What is going on in africa and why did they have such low rates of infection

139:31and and death?

139:32Well, first of all, we have to be really cautious about saying how many cases

139:38they've had

139:39Because there's a lot of surveillance surveillance and testing

139:42And I mean if you look for example at south africa where we have better testing

139:47we have better

139:47Follow-up you did see increased number of cases if you look at zimbabwe

139:52You look at countries like that and so part of it is that

§28Transcript · 2:19:56–2:25:34

139:56Surely it's not the same as the us. We're not seeing the hospitalizations the

140:02same way

140:03But then we have a much younger age population

140:05You know any of those conditions that could predispose if you know your median

140:10age is 20 or 30 years younger than it is in

140:13A high-income country right there you have an advantage in terms of likelihood

140:17of having severe illness

140:19But I think at the same time

140:21We're trying to study that to understand how many cases did we miss did we miss

140:25what are the impacts

140:26And it's been particularly important in africa for a separate reason is because

140:30public health services have been so disrupted there because of covid

140:34Levels of vaccination malaria control maternal and child health all these other

140:39issues are taking a huge toll right now

140:42And I mean we're really going to have to reinvest back into that area just

140:46because

140:47You know we've lost a lot of footing in our control

140:50From a public health standpoint of many of infectious diseases is there any

140:54other factors that could be

140:55A consideration in terms of like the low rates of infection do you think that

141:01it's just a lack of reporting and testing

141:03Or is it possible that there's other medications that they've been taking that

141:08could have contributed to their low numbers of infections?

141:11Well again, I come back and say that it's not

141:15Just the fact of underreporting as I pointed out you know if you have a much

141:18younger age population

141:19You can see big differences in the rate of serious illness hospitalizations,

141:25etc. Just by that alone

141:26In terms of any of the factors such as has been suggested could certain drugs

141:31that they may take or how often do they take those drugs could play a role

141:34You know i'm at this point again open to the data

141:37You know we just have seen so little come out of africa and we need more we

141:41need much more information

141:42Understand that I think the south african experience was helpful in allowing us

141:48to see what omicron was going to do

141:50Now however, we're in a place where even looking at south africa

141:54That big burst of cases has come down, but it's not going away. It's there's a

141:59tail here. That's pretty substantial

142:01Why is that what's going on in south africa? So I think the

142:06African continent has been largely

142:08Neglected relative to many other parts of the world to better understanding

142:13what colbert has done both directly and indirectly to the society

142:17Were there any countries do you think that were a model of how to handle the

142:22pandemic correctly?

142:26You know, I think trying to make the very best out of a horrible situation

142:30I think australian new zealand have probably done as well as any two countries

142:34and you can say well, they're islands

142:36But you know, they they pursued this zero covet policy to the extent that they

142:41could and when it became impossible with omicron

142:43They graduated their response in a way, you know that I think is really helpful

142:49I mean, just take for example new zealand

142:52Here's a country that with you know 5.2 million people here's minnesota state.

142:57I'm from you know with 5.6 5.7 million

143:00You know when you look at our deaths, you know, we've had you know 12 000

143:06almost

143:06Look at their deaths. They've had 52 as of two weeks ago

143:10What's different?

143:12Well, I think in part it's because they did try early on to really have major

143:16control and then allow

143:19Things to be relaxed when you know, the numbers didn't appear to be increasing

143:23or you know the follow-up

143:24And so I think there's lessons here for us to learn across the board all

143:28countries need to go back and look carefully at it

143:31A very interesting piece in the financial times a couple of weeks ago

143:35David Byrne murdoch who I think is one of the most wonderful

143:38Journalists today in this topical area

143:41Did an analysis looking at what had what happened during the omicron surge in

143:47the united states

143:48If in fact, we had the same immunization rates for covid as denmark

143:52And he estimated that about half of all the hospitalizations would have been

143:56eliminated half

143:58And I think that's probably true. That's why if you see now you see lots of

144:02cases in denmark occurring as they've opened up everything

144:05But the number of hospitalizations and people in icus have gone down

144:09Because again, they're actually providing protection against serious illness

144:13hospitalizations and deaths with their immunization programs

144:16And I think that's a lesson for us going forward. How do we make that work so

144:20that we can do more of the same?

144:22Now, what is your take on doctors like the

144:25FLCC that had this early treatment protocol for covid

144:30that has been widely disparaged by

144:34other people like you know the ivermectin hydroxychloroquine

144:39azithromycin

144:41All that stuff together like what do you what do you think about these doctors

144:45that had put out these

144:46Protocols for early treatment well, I don't have an opinion of the doctors. You

144:51know, I have opinion on the protocols

144:52Well, I'm gonna say yes. I I think again it has to be science driven

144:57You know, and as I just said earlier in our discussion

145:00I think the data coming out on these five trials with ivermectin is going to be

145:05very interesting. I am eyes wide open

145:06You know, I'm ready to see them these double blind placebo control

145:10Have you looked at any of the randomized controlled trials that have been done

145:13previously?

145:13You know, there were none that were really

145:15Randomized controlled trials I can tell you I look at the studies carefully

145:19There were so many problems the one in brazil was really a challenge. I mean it

145:25Again going back to my previous statement if one of my graduate students had

145:28done that kind of a study out of flunked them

145:30So I think we need really much more comprehensive data

§29Transcript · 2:25:34–2:29:06

145:34And we should be collecting data on these kinds of treatments

145:37So I'm I hope everyone can agree if you do a double blind placebo controlled

145:42trial

145:42That means that neither the patient nor the investigator knows who got the drug

145:47and who didn't everybody is otherwise the same

145:49They're equal it's only when the code is broken by the monitoring board

145:53Does anybody know what the results were then we can feel confident that we have

145:58a study that is objective

145:59That is based on the data and you know if ivermectin comes out working you'll

146:04hear me say it

146:05If it doesn't i'll explain what I think the study said and what it meant

146:09So i'm i'm wide open on all of these things

146:12I just if I had to say anything that I wish

146:15We learn from this is some of these things have to be done much sooner

146:19And agreed I think a year ago people thought we were done

146:22I wish we had started some of these trials. I wish we had done some randomized

146:27controlled trials on masking

146:28And how does it make it work? You know, what can you do?

146:32Maybe you can't what can you do and maybe inform people about what you were

146:35saying about n95s?

146:36Exactly and then and then share that information as quickly as possible tell

146:40the story

146:42You know I you know you you understand this but you know

146:46People really respond to when you tell them a story

146:50You know I learned a long time ago as a kid growing up in rural iowa

146:54That if I wanted to try to make a point or to try to put forward a position

146:59If I couldn't get it to sell

147:01At the ten o'clock coffee group at the s&d cafe in my little hometown in iowa

147:06You know, I needed to go back home and rethink it

147:09How do you get that to sell?

147:11And you don't do it by being a salesman you do it by just being a good storyteller

147:16Telling the truth telling what you know and don't know

147:18And I think that's what we need to do a better job of in public health right

147:22now

147:22We need to be that we need to code it all all in a dose of humility say what do

147:28I know and don't know?

147:29I mean, you know what this interview will probably remember for how many times

147:32I told you that I don't know

147:34Well that and I mean, I think you gave a a great analysis of things that went

147:40wrong and things that we could have done better

147:41And also the burden on the healthcare providers. I think that's something that

147:46people need to be really reminded of

147:48Thank you

147:50Okay, your podcast is the olstrom update podcast every thursday

147:56Every thursday morning it drops and it's on our website. It's on apple. It's on

148:01spotify. It's on all of the services out there and

148:04Welcome it. I try it's again my attempt just to be

148:09Unvarnished to be humble and just to tell you what I know and don't know

148:13Well, thank you very much for that and I appreciate you coming back again and

148:17hopefully we won't have to do this again in two years

148:19Well, if we do it won't be on this topic. Yeah, hopefully. Yeah. Well,

148:23hopefully it won't be a new one, right?

148:24Yeah, all right. Thank you very much. Thanks a lot. Thank you. Bye everybody

148:36You

— 读到这里,多懂一点。 —